Category: ACN Newswire

HONG KONG, Apr 16, 2026 - (ACN Newswire via SeaPRwire.com) - InnoEX, jointly organised by the Innovation, Technology and Industry Bureau (ITIB) of the Hong Kong SAR Government and the Hong Kong Trade Development Council (HKTDC), and the HKTDC’s Hong Kong Electronics Fair (Spring Edition) (EFSE), both concluded today. The four-day exhibitions were a resounding success, attracting over 88,000 buyers from 155 countries and regions for connection building and business matching. Buyers from outside Hong Kong mainly came from the Chinese Mainland, Japan, India, the United States, and Korea, among others.Jenny Koo, Deputy Executive Director of the HKTDC, said: "InnoEX and EFSE bring together elites from the global innovation, technology, and electronics industries, and leverage Hong Kong's unique advantage of connecting the Chinese Mainland and the world. The HKTDC provides a crucial platform connecting global innovation and technology by assisting Chinese Mainland enterprises in expanding overseas and seizing global business opportunities and also offering global enterprises a springboard to enter the Asian and Chinese Mainland markets. The HKTDC helps enterprises from various regions master cutting-edge technologies, promotes in-depth cross-industry and cross-sectoral exchanges and application transformation, and also promotes Hong Kong's development as an international innovation and technology hub."Both exhibitions align with China’s 15th Five-Year Plan and the innovation and technology policies in the Hong Kong Government’s latest Budget, which focus on cutting-edge technologies and market applications driven by AI. The newly launched RoboPark brought together technology companies from Hong Kong, the Chinese Mainland and overseas. RoboPark featured over 100 robots in a variety of application scenarios. Among the exhibitors at the RoboPark, UBTECH is the world’s first humanoid robot company listed in Hong Kong. As one of the top five global humanoid robot vendors by sales[1], UBTECH engaged with potential buyers from the Chinese Mainland, the United States, Europe and Southeast Asia during the fair. The company reported that its participation delivered results well beyond expectations, underscoring the exhibition’s strong international reach.Global buyers gather and enterprises expand into overseas markets via exhibitionsInnoEX focused on five key areas: AI+, Robotics, the Low-altitude Economy, Property Technology and Retail Technology, presenting a comprehensive showcase of innovation and cutting‑edge technology solutions. The fair brought together exhibitors from 21 countries and regions. Both the UK Pavilion and the Macao Pavilion welcomed the strong turnout of high‑quality buyers, with exhibitors from the Macao Pavilion alone holding more than 280 business meetings during the first three days of the exhibition.In addition, the exhibition featured participation from universities, research institutes and leading technology enterprises, including Huawei, China Mobile Hong Kong, HKT and Lenovo. Beyond exhibiting, Huawei organised Huawei Hong Kong Tech Week 2026 concurrently with InnoEX. Through 12 themed events and industry‑specific forums, Huawei explored innovative applications and real‑world practices of Artificial Intelligence+ across various sectors, generating strong synergy with InnoEX and further enriching the exhibition’s thought‑leadership programme.The Chinese Mainland pavilions comprised from 17 provinces and municipalities. Among them, Zhongguancun Beijing Hong Kong-Macao Youth Innovation Center which has been bringing delegations to the fair since its inaugural edition, said that the 10 high‑quality technology enterprises in this year’s delegation span a wide range of frontier technology sectors, including artificial intelligence, intelligent robotics, the low altitude economy and application‑specific chips. On the first day of the exhibition alone, the delegation attracted strong interest from relevant institutions and enterprises from Brazil, Germany, India, Japan, Malaysia, South Korea and the Middle East.EFSE showcased smart living electronics and new products attracting buyers' attentionThe EFSE presented three major areas, including Smart Home & Solutions, Health Tech & Gadgets, and Pet Intelligence, with around 60 products being launched for the first time. Among them, local company HelloBaby, which specialises in the research, development and sales of baby monitor products, showcased its latest product at the fair. Qin Zhihui, Sales Director at HelloBaby, said: “The exhibition is highly international in character, and we participate every year. Our buyers mainly come from Japan, Korea, Singapore and other Asian markets.”Buyers noted that EFSE is a strong brand‑focused platform, enabling companies to connect successfully with Chinese Mainland and global markets through Hong Kong’s international platform. Carmate Electronics Pty Ltd, an Australian manufacturer of automotive electronics, said it had successfully engaged with a number of high‑quality buyers from markets, including Brazil, Mexico, Belgium and Indonesia, through EFSE. The company recorded potential transactions of around US$200,000 on the first day and expects follow‑up orders to reach US$400,000 to US$500,000. Michael Lin, General Manager of the company, noted that amid heightened China‑US tensions, Hong Kong’s unique role as an international platform has positioned the city as an important bridge between overseas and Chinese Mainland enterprises, generating valuable business opportunities. He described the exhibition as highly fruitful and confirmed the company’s participation again next year.In addition to one‑stop sourcing, buyers also gained valuable insights into industry trends. Pari Jazz, a buyer from Germany‑based P.J Global Way Management Ltd, said that the exhibition not only enabled her to place orders, but also helped her stay abreast of the latest market trends and technological developments. Overall, she found the experience highly rewarding. During the fair, she arranged around 12 business meetings, engaging with exhibitors from Hong Kong, the Chinese Mainland and Denmark, meeting approximately 10 to 13 contacts in total, and identifying two to three potential partners with good prospects for collaboration.Over 100 events with 260+ speakers decoding new industry trendsInnoEX and EFSE invited many well-known technology companies, industry experts and scholars to share the latest industry trends, technological innovations and practical experiences with buyers, promoting in-depth exchange and cooperation. This year, more than 260 speakers shared their insights across the fair’s five major thematic areas.In the area of AI+, the Hong Kong Computer Society co-organised the session ‘From +AI to AI+: Enhancing Workplace Performance’ during the exhibition, where representatives from HKT Limited, Lenovo and CLP joined other industry leaders to exchange insights and foster greater innovation collaboration. InnoEX, for the first time, co-organised the ‘Low-altitude Economy Development Conference’ with the Working Group on Developing Low-altitude Economy and the Greater Bay Area Low-altitude Economy Alliance. Distinguished guests included Michael Wong, Deputy Financial Secretary of the HKSAR; Liu Chun-san, JP, Under Secretary for Transport and Logistics, HKSAR Government; Bakhtiyar Mukhametkaliyev, Vice Minister of Artificial Intelligence and Digital Development of Kazakhstan; and Professor Zhang Qingxin of the Liaoning General Aviation Academy, who shared insights on the development opportunities of the low-altitude economy across Hong Kong, the Chinese Mainland, ASEAN and Central Asia.Another highlight was the thematic seminar ‘Embodied AI in Robotics: The Dawn of Autonomy,’ which explored the rise of embodied artificial intelligence in robotics, marking a new era where autonomous systems are capable of independent decision-making and executing complex tasks. Distinguished speakers included Prof Xuguang Lan from the School of Artificial Intelligence at Xi’an Jiaotong University and Kristine Mo, Vice President of Global Market and Ecosystem at AI² Robotics, who shared how AI-driven robotics are transforming industries such as education, entertainment and services, while delving into technological breakthroughs, ethical considerations and future applications.Some 80% of respondents have explored or adopted generative AI technologiesTo further understand the development trends of the innovation and technology as well as the electronics industry, an independent institution was appointed to conduct surveys during the fairs, interviewing 347 exhibitors and buyers at InnoEX and 648 exhibitors and buyers at EFSE. Key findings are as follows:InnoEX and EFSE81% of respondents expressed interest in expanding into emerging markets, including Europe, ASEAN, the Chinese Mainland, and Latin America.78% of respondents indicated that their companies have already explored or adopted generative AI technologies.InnoEXIn terms of applications of generative AI, 42% of respondents said they have applied or are planning to apply it to sales and customer communications, 40% to data analysis and reporting, while 39% plan to deploy it in product design and research and development.EFSE59% of respondents expect their overall sales revenue to increase in the next one to two years.33% of respondents believe that, compared with traditional electronic products and appliances, consumers are willing to pay a premium of 11% to 20% for products that support smart home or artificial intelligence applications.[1]Source: Omdia Market Radar: General-purpose Embodied Intelligent Robots, 2026, published on 8 January 2026.Photo download: https://bit.ly/3Qt7Fd3InnoEX, jointly organised by the Innovation, Technology and Industry Bureau (ITIB) of the HKSAR Government and the Hong Kong Trade Development Council (HKTDC), and the HKTDC’s Hong Kong Electronics Fair (Spring Edition) (EFSE), successfully concluded today, attracting over 88,000 buyers from 155 countries and regions for connection building and business matchingThe newly launched RoboPark brings together technology companies from Hong Kong, the Chinese Mainland and overseas, featuring over 100 robots and hosting approximately 40 eventsInnoEX brings together exhibitors from 21 countries and regions, including 18 Chinese Mainland delegations from 17 provinces and cities. The photo is Guangdong delegationInnoEX partnered with the Working Group on Developing Low-altitude Economy for the first time to set up a Low‑Altitude Economy Zone, showcasing low altitude technology applications and promoting industry cooperationInnoEX and EFSE invited many well-known technology companies, industry experts, and scholars to share the latest industry trends. More than 260 speakers shared their insights across the fair’s five major thematic areas. The photo is the Hong Kong Computer Society co-organised the session ‘From +AI to AI+: Enhancing Workplace Performance’ during the exhibitionMany leading technology companies made a strong presence at InnoEX, engaging in in‑depth exchanges with global buyers and industry partners.During the exhibition, Dean Ward, representative of UK Pavilion exhibitor PropSmarts, successfully concluded a partnership and licensed distribution agreement with a geographic information system (GIS) software companyThe Retail 4.0: Reshaping Consumer Experiences seminar invited many industry leaders, including representatives from the Hong Kong Retail Management Association, DECATHLON Hong Kong, Tradelink Electronic Commerce Limited, Adyen, Visa, and Tencent Cloud, to discuss the innovative trends and future direction of the retail industryInnoEX, for the first time, co-organised the “Low-altitude Economy Development Conference” with the Working Group on Developing Low-altitude Economy and the Greater Bay Area Low-altitude Economy Alliance. Distinguished guests included Michael Wong, Deputy Financial Secretary of the HKSAR and Bakhtiyar Mukhametkaliyev, Vice Minister of Artificial Intelligence and Digital Development of Kazakhstan, who shared insights on the development opportunities of the low-altitude economyHong Kong Electronics Fair (Spring Edition) (EFSE) features an Immersive Experience Zone, where local innovation and technology companies present immersive interactive games using VR, AR and XR technologies.WebsitesInnoEX: innoex.hktdc.com/enHong Kong Electronics Fair (Spring Edition): hkelectronicsfairse.hktdc.com/enMedia enquiriesYuan Tung Financial Relations:Salina Cheng Tel: (852) 3428 2362 Email: salcheng@yuantung.com.hkTiffany Leung Tel: (852) 3428 2361 Email: tleung@yuantung.com.hkHKTDC’s Communications & Public Affairs Department:Stanley So Tel: (852) 2584 4049 Email: stanley.hp.so@hktdc.orgNavin Law Tel: (852) 2584 4525 Email: navin.cm.law@hktdc.orgSerena Cheung Tel: (852) 2584 4272 Email: serena.hm.cheung@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

General Wayne Eyre to Strengthen Focus Graphite's Engagement with Defence and Allied Partners Across Critical Supply ChainsOttawa, Ontario--(ACN Newswire via SeaPRwire.com - April 16, 2026) - Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0) ("Focus" or the "Company"), a Canadian developer of high-grade flake graphite deposits and advanced graphite materials for battery, defence, and industrial applications, is pleased to announce the appointment of General (Retired) Wayne Eyre, former Chief of the Defence Staff ("CDS") of the Canadian Armed Forces ("CAF"), to its Advisory Board.This appointment comes at a time when global security priorities are increasingly shaped by access to secure, reliable supply chains for critical minerals essential to defence systems, energy storage, and advanced technologies.General Eyre served more than forty (40) years in the CAF, culminating as CDS from 2021 to 2024, where he led Canada's military through a period of rapidly evolving geopolitical and security challenges. Throughout his career, he commanded at all levels, including the Canadian Army and Military Personnel Command. He served on numerous overseas missions including in the Former Yugoslavia, Afghanistan, and as Deputy Commander of United Nations Command in Korea, where he was the most senior Canadian officer ever permanently stationed in the Asia Pacific region.He brings extensive operational and institutional experience across U.S. and allied defence systems, including completion of the U.S. Army Special Forces Qualification Course, the U.S. Marine Corps Command and Staff College, the U.S. Marine Corps School of Advanced Warfighting, and the U.S. Army War College. General Eyre holds a Bachelor of Science and three master's degrees in Military Studies, Operational Studies, and Strategic Studies.His decorations include the Commander of the Order of Military Merit, the Meritorious Service Cross, and multiple international honours from allied nations, recognizing his leadership and service across the globe. He is currently a Visiting Professor and Senior Fellow at the University of Ottawa's Graduate School of Public and International Affairs, and continues to advise on global security, defence transformation, and strategic leadership.In his role with Focus, General Eyre will provide strategic guidance on defence-related applications of graphite, support engagement with allied and NATO-aligned partners, and advise on positioning the Company within evolving North American and allied critical minerals frameworks."Our high-quality material and thermal purification process lends itself to defence and advanced systems," said Dean Hanisch, CEO of Focus Graphite. "General Eyre's leadership at the highest levels of the Canadian Armed Forces, combined with his deep experience across NATO and allied operations, brings critical insight to our strategy. His perspective will help position Focus Graphite as a trusted supplier supporting defence, energy, and advanced material systems across allied nations.""The character of modern security is changing, with supply chains becoming as critical as the systems they support," said General Wayne Eyre. "Materials like graphite are foundational to energy storage, advanced technologies, and defence readiness. Focus Graphite is well positioned to contribute to strengthening secure, sovereign supply chains, and I look forward to supporting the Company as it advances its role within Canada and across NATO partners."This appointment further strengthens Focus Graphite's positioning at the intersection of critical minerals, defence readiness, and advanced materials development. The Company continues to advance its Lac Knife and Lac Tetepisca projects, alongside downstream processing initiatives, to support a secure and resilient North American supply chain.About Focus Graphite Advanced Materials Inc. Focus Graphite Advanced Materials is redefining the future of critical minerals with two 100% owned world-class graphite projects and cutting-edge battery technology. Our flagship Lac Knife project stands as one of the most advanced high-purity graphite deposits in North America, with a fully completed feasibility study. Lac Knife is set to become a key supplier for the battery, defense, and advanced materials industries.Our Lac Tetepisca project further strengthens our portfolio, with the potential to be one of the largest and highest-purity and grade graphite deposits in North America. At Focus, we go beyond mining - we are pioneering environmentally sustainable processing solutions and innovative battery technologies, including our patent-pending silicon-enhanced spheroidized graphite, designed to enhance battery performance and efficiency.Our commitment to innovation ensures an eco-friendly supply chain from mine to market. Collaboration is at the core of our vision. We actively partner with industry leaders, research institutions, and government agencies to accelerate the commercialization of next-generation graphite materials. As a North American company, we are dedicated to securing a resilient, locally sourced supply of critical minerals - reducing dependence on foreign-controlled markets and driving the transition to a sustainable future.For more information on Focus Graphite Inc. please visit http://www.focusgraphite.comLinkedIn: https://www.linkedin.com/company/focus-graphite/X: https://x.com/focusgraphiteInvestors Contact:Dean HanischCEO, Focus Graphite Inc.dhanisch@focusgraphite.com+1 (613) 612-6060Jason LatkowcerVP Corporate Developmentjlatkowcer@focusgraphite.comCautionary Note Regarding Forward-Looking StatementsCertain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could," "intend," "expect," "believe," "will," "projected," "estimated," and similar expressions, as well as statements relating to matters that are not historical facts, are intended to identify forward-looking information and are based on the Company's current beliefs or assumptions as to the outcome and timing of such future events.In particular, this press release contains forward-looking information regarding, among other things, the anticipated contributions of General Wayne Eyre in his role as an advisor to the Company; the Company's ability to leverage his experience to support engagement with defence stakeholders, NATO-aligned partners, and allied supply chain initiatives; the growing importance of secure, North American sources of graphite for defence, energy storage, and advanced technologies; and the Company's plans and objectives for advancing its Lac Knife and Lac Tétépisca projects, downstream processing capabilities, and broader critical minerals strategy.Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, risks related to market conditions, regulatory approvals, changes in economic conditions, the ability to raise sufficient funds on acceptable terms or at all, operational risks associated with mineral exploration and development, and other risks detailed from time to time in the Company's public disclosure documents available under its profile on SEDAR+.The forward-looking information contained in this release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties, and assumptions contained herein, investors should not place undue reliance on forward-looking information.Neither TSX Venture Exchange nor its Regulation Services accepts responsibility for the adequacy or accuracy of this release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/292837 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Apr 16, 2026 - (ACN Newswire via SeaPRwire.com) - Sigenergy Technology Co., Ltd. (“Sigenergy” or “the company” Stock Code: 06656.HK) officially commenced trading on the Main Board of the Hong Kong Stock Exchange (HKEX) today. As the first “AI + All-in-One PV Storage” company to list on the exchange, Sigenergy has set a new record for the fastest IPO by a Chinese enterprise.The stock showed strong momentum on its debut, opening at HK$ 581, representing almost an 80% increase over the offer price. Market cap exceeded HK$140 billion. Based on the offer price of HK$324.20 per share, the company raised over HK$4.4 billion in its IPO. If the over-allotment option (greenshoe) is exercised in full, the total proceeds will reach HK$5.06 billion.A Milestone for the Company, the Beginning for a New ChapterFounded only 3 years and 11 months ago, Sigenergy’s rapid path to listing reflects its focus on defining new industry standards rather than following short-term market trends. The IPO attracted a prestigious group of cornerstone investors, highlighting the company’s strategic value in the 2026 Hong Kong market.At the listing ceremony, Mr. Xu Yingtong, Founder and CEO of Sigenergy, together with Mr. Zhang Xianmiao, President of Sigenergy, witnessed this pivotal milestone in the company’s journey.Mr. Xu Yingtong stated: “Listing marks a new beginning for us. Guided by our ‘AI in All’ mission, we are doubling down on energy storage and accelerating R&D to fortify our competitive edge. Our goal is to ensure that AI translates into tangible value for our customers. As we advance our global expansion and refine our international network, we are proud to share the story of ‘China’s Intelligent Manufacturing’ in the renewable energy sector. We promise to uphold the highest standards of operational excellence, rewarding your trust with exceptional results and building a legacy as a transparent, reliable, and socially responsible enterprise.” Sigenergy’s cornerstone investors include world-class sovereign wealth funds and asset managers such as Temasek, Goldman Sachs Asset Management, UBS Asset Management, and BNP Paribas Asset Management. Other notable participants include Hillhouse, CPE, Boyu Capital, Gaoyi Asset Management, and Greenwoods Asset Management, alongside insurance and specialized funds like CPIC, ORIX, and Walden International.This diverse group of high-caliber investors signals a strong market consensus: Sigenergy is recognized as a unique player in the “AI + All-in-One PV Storage” sector, underpinned by proprietary technology, high entry barriers, and predictable growth. Beyond a mere endorsement of the company, this capital influx confirms the market’s conviction that “AI-native” architecture is the definitive standard for next-generation energy storage.Market confidence is supported by Sigenergy’s rapid scale-up. According to the prospectus, the company’s revenue grew from RMB 58.30 million in 2023 to RMB 9.00 billion in 2025, increased 154.4 times in two years. During this period, gross margins expanded from 31.3% to 50.1%, with an adjusted net margin reaching 35.9%. These figures validate the commercial viability of Sigenergy’s “AI-native” technology path.Differentiation Through “AI-Native” TechnologyUnlike traditional “hardware-first, AI-enabled” peers, the company established a more thorough “AI-native” path by integrating artificial intelligence across product design, manufacturing, and business models, the company has achieved a system that is inherently intelligent and capable of continuous evolution.Its flagship product, SigenStor, is a five-in-one system that combines an inverter, EV DC charging module, and battery pack into a modular, stackable unit which achieves a deep integration of power electronics, cloud and AI technologies, enhances product performance while delivering a more convenient user experience.The actual value of system’s “AI-native” capabilities is particularly effective in markets with dynamic electricity pricing. Facing fluctuations on an hourly or even minute-by-minute basis, traditional “charge at low, use at high” strategies based on fixed rules are no longer sufficient. By analyzing real-time prices, weather forecasts, and consumer habits, the system optimizes energy scheduling. In the Swedish market, SigenStor helped users reduce electricity costs by an average of 70.3%, showing the effective translation from AI technology into tangible financial benefits.Sigenergy continuously strengthens its competitive edge through a “Data-Intelligence” closed-loop. As global install base grows, the system leverages real-world operational data to undergo autonomous learning and optimization. This evolution directly translates into superior economic returns for users, which in turn fosters brand loyalty and higher retention. This data-driven cycle creates a powerful network effect, establishing a formidable, long-term barrier to entry in the Energy AI sector.Since its launch, SigenStor has established a strong global presence through its unique value proposition. According to Frost & Sullivan, Sigenergy has become the world No.1 provider of stackable distributed PV and storage all-in-one solutions in 2024, securing a 28.6% market share. Further data from SunWiz confirms that in 2025, the company ranked first in the under-1000kWh segment across Australia, Ireland, and South Africa, while maintaining a top-tier position in the UK, Sweden, and the Netherlands. This deep penetration into high-value markets has delivered significant commercial returns and reinforced Sigenergy’s brand equity. As the company expands into the Asia-Pacific and Latin American regions, its growth trajectory remains robust.To support the trajectory, the company has built a robust manufacturing footprint with production bases in Lingang and Jinqiao, Shanghai, as well as Nantong, Jiangsu. By the end of 2025, the company achieved an annual design capacity of nearly 360,000 inverters and over 5.6 GWh of energy storage batteries. This infrastructure provides a stable foundation for the company’s ongoing global expansion.The successful HKEX listing marks a significant milestone in Sigenergy’s commitment to innovation and recognizes its substantial growth potential. Entering this new chapter, and with the support of premier institutional investors, Sigenergy will focus on optimizing resource integration and accelerating its global ‘AI + Energy Storage’ strategy. By solidifying its technological leadership and market presence, the company aims to build a sustainable foundation for long-term value creation.For inquiries, please contact:EVER BLOOM (HK) COMMUNICATIONS CONSULTANTS GROUP LIMITEDMs. Claire ZhangTel: (852)3468 8171Email: project_alps.list@everbloom.com.cn Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

台北, 2026年4月16日 - (亚太商讯 via SeaPRwire.com) - OBI Pharma, Inc.（TPEx:4174.TWO）今日宣布将出席 AACR 2026 年会，并通过十篇海报展示其 GlycOBI® 平台的变革性潜力。传统 ADC 常因随机偶联而受到限制，导致药物与抗体比值（DAR）不均一、稳定性不足以及治疗窗口狭窄。相比之下，OBI 的位点特异性糖链技术可实现高度均一的 DAR，从而带来更优的 PK/PD 特征，并降低脱靶毒性，这一点已在 OBI 的主要项目 OBI-902 和 OBI-904 中得到验证。我们正通过新一代双特异性（OBI-201）以及双特异性双载荷（OBI-221）ADC 推动精准肿瘤学的进一步发展。这些“以生物学驱动”的分子旨在克服肿瘤异质性和多药耐药性——这是当前癌症治疗中的关键挑战。通过结合 GlycOBI® 与 GlycOBI DUO® 平台，OBI 正在开发具有创新性和差异化的疗法，以满足难治性实体瘤患者尚未被满足的医疗需求。此外，OBI 强大的 ADC 偶联平台已被证明能够稳定实现产品质量与可扩展性，同时支持向下一代治疗模式拓展，包括降解剂-抗体偶联物（DAC）。这些数据将于 2026 年 4 月 17 日至 22 日在美国加利福尼亚州圣地亚哥举行的美国癌症研究协会（AACR）年会上展示。“在 OBI，我们致力于打造更优质的 ADC，”OBI Pharma 首席科学官陈雅琪博士表示。“我们的目标是提供不仅能够更有效、更精准靶向肿瘤，同时还能减少副作用的疗法，为患者带来具有潜在改变生命意义的治疗选择。”2026年4月20日（星期一）（上午9:00 - 12:00）标题：通过 OBI-902 克服耐药性：下一代 TROP2 ADC 的临床前评估1 作者：Ren-Yu Hsu, Chi-Huan Lu, Chi-Sheng Shia, Jing-Rong Huang, Hsin-Shan Wu, Lu-Tzu Chen, Jhih-Jie Yang, Tzu-Min Yen, Jyy-Shiuan Tu, Yu-Hsuan Tsao, Ya-Chi Chen。OBI Pharma, Inc，台湾台北 会议主题：PO. ET07.01 - 定量药理学与转化建模 地点：海报区 17 海报编号：6 摘要编号：1818标题：OBI-904，一种靶向 Nectin-4 的下一代 Exatecan ADC，展现出增强的细胞毒性并克服 Enfortumab Vedotin 耐药性2作者：Yuan-Liang Wang, Chi-Huan Lu, Woan-Eng Chan, Shin-Jin Lin, Ting-Yu Chang, Hong-Syuan Lin, Wei-Jhen Huang, Ya-Chi Chen。OBI Pharma, Inc，台湾台北会议主题：PO.ET02.02 - 抗体药物偶联物与连接子工程 2 地点：海报区 13 海报编号：26 摘要编号：1729标题：OBI-904，一种基于糖链的位点特异性靶向 Nectin-4 的 ADC，在非临床研究中展现出强效且持久的抗肿瘤活性，并具有改进的 PK 特征及克服 EV 耐药性的能力3 作者：Chi-Huan Lu, Ren-Yu Hsu, Jing-Jie Ciou, Tzu Min Yen, Jyy-Shiuan Tu, Yu-Hsuan Tsao, Jing-Rong Huang, Ya-Chi Chen。OBI Pharma, Inc., 台湾台北会议主题：PO.ET07.01 - 定量药理学与转化建模 地点：海报区 17 海报编号：7 摘要编号：1819标题：具有双载荷的 MET/HER3 抗体药物偶联物：一种消除肿瘤逃逸机制的双靶点策略5 作者：Yuan-Liang Wang, Chi-Huan Lu, Woan-Eng Chan, Ting-Yu Chang, Hong-Syuan Lin, Cheng-Yen Wei, Shin-Jin Lin, Lu-Tzu Lu, Meng-Hsin Liu, Wei-Jhen Huang, Ya-Chi Chen。OBI Pharma, Inc., 台湾台北会议主题： PO.CL.0705 - 靶向抗原疗法与免疫 地点：海报区 49 海报编号：17 摘要编号：2665标题：引导-效应 bsADC：通过协同内吞作用提升载荷递送效率6作者：Wei-Jhen Huang, Woan Eng Chan, Meng-Hsin Liu, Yueh Chin Wu, Ya-Chi Chen。OBI Pharma, Inc., 台湾台北会议主题： PO.ET02.02 - 抗体药物偶联物与连接子工程 2 地点：海报区 13 海报编号：27 摘要编号：1730标题：亲水性增强的连接子技术实现位点特异性的降解剂-抗体偶联物，具有改进的稳定性和增强的活性7 作者：Yu-Hung Chen, Wei-Chien Tang, Chi-Dian Lu, Hung-Yi Lin, Wei-Jhen Huang, Nan-Hsuan Wang, Ya-Chi Chen, Teng-Yi Huang。OBI Pharma, Inc., 台湾台北会议主题：PO.ET02.02 - 抗体药物偶联物与连接子工程 2 地点：海报区 13 海报编号：28 摘要编号：1731标题：基于细胞的载荷释放揭示双载荷 ADC 中设计、位点及细胞依赖的比例变化8 作者：Nan-Hsuan Wang, Wei-Han Lee, Evelyn He, Li Chuan Huang, Yu-Chao Huang, David Teng-Yi Huang, Ya-Chi Chen。OBI Pharma, Inc., 台湾台北会议主题： PO.CH01.06 - 抗体、抗体药物偶联物与核酸 地点：海报区 38 海报编号：5 摘要编号：23972026 年 4 月 20 日（星期一）（下午 2:00 - 5:00）标题：TROP2 上调及其与 HER2 的相互作用介导曲妥珠单抗耐药性4 作者：Yuan-Liang Wang, Chi-Huan Lu, Cheng-Yen Wei, Jye-Yu Huang, Woan-Eng Chan, Lu-Tzu Chen, Ya-Chi Chen。OBI Pharma, Inc., 台湾台北会议主题：PO.ET03.06 - 药物耐药性 1：抗体与 ADC 地点：海报区 12 海报编号：18 摘要编号：29722026 年 4 月 21 日（星期二）（上午 9:00 - 12:00）标题：基于糖链的位点特异性 ADC 通过改进的载荷递送和免疫激活实现持续的肿瘤控制9 作者：Liu Chih-Chun, Tsai Yi-Chien, Huang Jing-Rong, Lo Fei-Yun, Pei Yu, Hsu Ren-Yu, Tu Tzu-Hsuan, Chen Ya-Chi。OBI Pharma, Inc., 台湾台北会议主题： PO.IM02.04 - 癌症中的适应性免疫 地点：海报区 6 海报编号：2 摘要编号：4234标题：通过新一代位点特异性糖链偶联与双载荷灵活性推进 ADC 治疗的发展10 作者：Wei-Chien Tang, Yu-Hung Chen, Chih-Kang Chang, Ting-Wei Liu, Hung-Yi Lin, Wei-Jhen Huang, Chi-Huan Lu, Ren-Yu Hsu, Nan-Hsuan Wang, Ya-Chi Chen, Teng-Yi Huang。OBI Pharma, Inc., 台湾台北会议主题： PO.ET02.03 - 抗体药物偶联物与连接子工程 3 地点：海报区 12 海报编号：1 摘要编号：4423电子海报将于 4 月 17 日太平洋时间中午 12:00 起在 AACR 虚拟会议平台上线供浏览，同时也将于 4 月 18 日起在 OBI Pharma 官网（www.obipharma.com）上线。1 AACR 2026 年年会摘要在线发布 https://www.abstractsonline.com/pp8/#!/21436/presentation/45832 AACR 2026 年年会摘要在线发布 https://www.abstractsonline.com/pp8/#!/21436/presentation/53853 AACR 2026 年年会摘要在线发布 https://www.abstractsonline.com/pp8/#!/21436/presentation/45884 AACR 2026 年年会摘要在线发布 https://www.abstractsonline.com/pp8/#!/21436/presentation/50305 AACR 2026 年年会摘要在线发布 https://www.abstractsonline.com/pp8/#!/21436/presentation/40516 AACR 2026 年年会摘要在线发布 https://www.abstractsonline.com/pp8/#!/21436/presentation/54007 AACR 2026 年年会摘要在线发布 https://www.abstractsonline.com/pp8/#!/21436/presentation/54018 AACR 2026 年年会摘要在线发布 https://www.abstractsonline.com/pp8/#!/21436/presentation/64749 AACR 2026 年年会摘要在线发布 https://www.abstractsonline.com/pp8/#!/21436/presentation/131110 AACR 2026 年年会摘要在线发布 https://www.abstractsonline.com/pp8/#!/21436/presentation/5403关于 OBI PharmaOBI Pharma 是一家处于临床阶段的全球肿瘤学公司，成立于 2002 年，总部位于台湾。公司与其子公司 OBI Pharma USA, Inc. 致力于开发创新癌症疗法，为具有紧迫医疗需求的患者提供新的治疗选择。OBI 的研究重点是新型抗体药物偶联物（ADC）。通过其专有的下一代偶联技术平台 Obrion™，OBI 建立了多样化的 ADC 设计模式。该平台整合了专有的偶联和连接子技术，包括 GlycOBI®、GlycOBI DUO®、EndoSymeOBI®、HYPrOBI®，以及新型不可逆半胱氨酸偶联技术 ThiOBI®，以推进下一代 ADC 解决方案。OBI 已开发出一系列下一代 ADC 项目，包括单特异性 ADC，如处于 I 期临床评估阶段的 OBI-902（TROP2）和 OBI-904（Nectin-4）；双特异性单载荷 ADC OBI-201（HER2 × TROP2）；以及双特异性双载荷 ADC OBI-221（cMET × HER3）。为拓展 HYPrOBI® 连接子技术的应用范围，OBI 进一步开发了 ThiOBI® 技术，以实现不可逆的基于半胱氨酸的偶联。除 ADC 项目外，OBI 的资产还包括 OBI-3424，这是一种同类首创的小分子前药，靶向 AKR1C3，可在醛酮还原酶 1C3 高表达的肿瘤中选择性释放强效 DNA 烷化剂。更多信息请访问 www.obipharma.com 。关于 OBI-902 和 OBI-992OBI-902 是一种靶向 TROP2 的抗体药物偶联物（ADC），携带强效拓扑异构酶 I 抑制剂载荷，以药物-抗体比值（DAR）为 4 杀伤肿瘤细胞。TROP2 在多种实体瘤中高度表达，如乳腺癌、肺癌、胆道癌、胆管癌（胆管细胞癌）、卵巢癌、胃癌等多种癌症类型，因此成为理想的癌症治疗靶点。OBI-902 是一种新型位点特异性糖链偶联 ADC，采用 OBI 专有的 GlycOBI® 平台，具有更高的稳定性和更强的亲水性。在多种肿瘤模型中（包括非小细胞肺癌、三阴性乳腺癌和胃癌），OBI-902 展现出显著的抗肿瘤疗效、改进的药代动力学特征以及良好的安全性。其 IND 已于 2025 年 4 月 30 日获得美国食品药品监督管理局（US FDA）批准，并分别于 2025 年 11 月 16 日和 12 月 5 日获得胆管癌及胃癌（包括胃食管结合部癌）的孤儿药资格认定。I/II 期临床试验（NCT07124117）正在进行中，I 期 a 部分预计于 2027 年上半年完成。OBI-992 是另一种靶向 TROP2 的抗体药物偶联物（ADC），通过基于半胱氨酸偶联的亲水性可酶切连接子，以药物-抗体比值（DAR）为 4 携带强效拓扑异构酶 I 抑制剂载荷。OBI-992 在体循环中保持稳定，并将该细胞毒性载荷递送至表达 TROP2 的肿瘤细胞，从而在避免脱靶毒性的同时实现肿瘤细胞杀伤。OBI-992 的 IND 申请已于 2024 年 1 月获得美国 FDA 批准，并于 2024 年 8 月获得用于治疗胃癌（包括 GEJC）的孤儿药资格认定。I/II 期研究（NCT06480240）已达到拟定的 II 期推荐剂量（pRP2D），I 期预计于 2027 年上半年完成。自 2021 年 12 月起，OBI 已获得 Biosion, Inc.（www.biosion.com）授予的 TROP2 靶向抗体氨基酸序列在除中国大陆、香港和澳门以外所有地区的独家许可。Biosion 在中国大陆、香港和澳门拥有该抗体序列的独家权利。OBI 在除中国大陆、香港和澳门以外的所有地区拥有 OBI-992 和 OBI-902 的商业权利，而 Biosion 在中国大陆、香港和澳门拥有相应的商业权利。关于 OBI-904OBI-904 是一种抗体药物偶联物（ADC），由特异性靶向 Nectin-4（Nectin 细胞黏附分子 4）的单克隆抗体构成，通过 OBI 专有的 GlycOBI® ADC 赋能技术，并在双功能酶 EndoSymeOBI® 和新型连接子 HYPrOBI® 的支持下，以药物-抗体比值（DAR）为 8 偶联强效拓扑异构酶 I 抑制剂载荷。该药物有望成为同类首创及同类最佳的基于糖链的 ADC，旨在靶向多种表达 Nectin-4 的癌症类型。在多种动物疾病模型中（包括头颈鳞癌、结直肠癌、三阴性乳腺癌、宫颈癌及肉瘤），其已显示出抗肿瘤活性；在猴重复给药毒性研究中，OBI-904 展现出良好的安全性，目前处于 IND 申请前开发阶段。关于 OBI-201OBI-201 是一种 TROP2 × HER2 双特异性 ADC，基于 OBI 的 GlycOBI® ADC 赋能技术构建，并偶联拓扑异构酶 I 抑制剂。值得注意的是，OBI 首次证明 HER2 与 TROP2 可在细胞表面相互作用并形成蛋白复合物——这一突破性发现得益于与专业 AI 药物研发合作伙伴的协作。与单特异性 TROP2 或 HER2 ADC 相比，OBI-201 具有多项优势。通过同时靶向两种抗原，它可扩大肿瘤覆盖范围，尤其适用于靶点表达异质性或表达水平较低的癌症。双靶向可增强肿瘤选择性、结合亲和力及内吞作用，从而提高载荷向癌细胞的递送效率，同时有望降低对正常细胞的毒性。OBI-201 还可能克服部分单特异性 ADC 治疗后因靶点下调所产生的耐药性。动物研究表明，在 HER2 表达极低的耐药性乳腺癌模型中，OBI-201 相较于单靶点 ADC 展现出显著更优的抗肿瘤活性。OBI-201 能够持续抑制肿瘤生长，显示出其克服多种耐药机制的潜力。OBI-201 是一种新一代双特异性 ADC，有望突破单靶点 ADC 的局限，为患者提供更全面且持久的治疗选择。关于 OBI-221OBI-221 是一种双特异性双载荷 ADC（BsDpADC），基于 OBI 的 GlycOBI DUO® 技术构建，靶向 cMET 和 HER3，并偶联 MMAE 与拓扑异构酶 I 抑制剂双载荷。在临床实践中，靶向 EGFR 的疗法已成为治疗非小细胞肺癌（NSCLC）和结直肠癌（CRC）的关键策略。然而，肿瘤常通过上调 cMET 和 HER3 快速产生耐药性，从而维持肿瘤生长。此外，在胃癌、头颈癌及多种其他实体瘤中也观察到 cMET 和 HER3 的高表达，进一步凸显了未被满足的医疗需求。为应对这一挑战，OBI Pharma 利用其专有的 GlycOBI DUO® 平台和 HYPrOBI® 连接子开发了新型双特异性双载荷抗体药物偶联物（BsDpADC）——OBI-221。该治疗药物可同时靶向 cMET 和 HER3，并递送具有协同作用的细胞毒性载荷，从而有效对抗肿瘤耐药性和异质性。这一突破性设计不仅满足未被满足的医疗需求，也代表了下一代 ADC 开发的前瞻性策略。OBI-221 在克服现有 EGFR 靶向疗法耐药性方面具有重要潜力，有望为患者提供更具针对性的治疗选择，并带来显著的临床价值。关于 GlycOBI®OBI 开发了一种独特的基于糖链的位点特异性 ADC 技术（GlycOBI®），采用即插即用（Plug and Play）设计，可兼容任意抗体、连接子和载荷，并支持多种药物-抗体比值（DAR）（最高可达 16）。该技术由 OBI 专有的双功能酶技术 EndoSymeOBI® 和亲水性连接子技术 HYPrOBI® 驱动，作为 OBI Obrion™ ADC 技术体系的核心组成部分，能够在 GMP 条件下通过高效、可规模化、流程简化的两步一锅法偶联工艺生成位点特异性且高度均一的 ADC。在偶联过程中，GlycOBI® 避免破坏抗体结构，并确保生成的 ADC 保持与天然抗体相当的生物物理特性。此外，OBI 的连接子技术提高了载荷偶联效率，并降低了聚集或降解的倾向，从而进一步支持稳定且可控的 ADC 生产过程。GlycOBI® 克服了传统 ADC 方法常见的局限，并在多项体内研究中展现出更优的抗肿瘤活性和稳定性。值得注意的是，该平台支持偶联细胞毒性小分子抑制剂以及高度疏水性的降解剂，从而拓展至包括 DAC 在内的下一代治疗模式。关于 GlycOBI DUO®GlycOBI DUO® 是一种基于 GlycOBI® 位点特异性偶联平台及其专有酶促偶联策略构建的下一代双载荷抗体药物偶联物（ADC）技术。该技术可在单一抗体上以可调比例精确、可编程地连接两种不同载荷，并支持高 DAR 比值（最高可达 DAR24）。通过结合互补的作用机制，GlycOBI DUO® 旨在增强抗肿瘤疗效、应对肿瘤异质性并提升整体治疗指数，同时具备克服传统 ADC 相关耐药机制的潜力，代表了下一代 ADC 开发的重要进展。关于 ThiOBI®OBI 开发了一种新型不可逆半胱氨酸偶联 ADC 平台（ThiOBI®），具有更高的稳定性，可适用于任意抗体、连接子和载荷。OBI 专有的 ThiOBI® 平台结合连接子技术（HYPrOBI®），可生成多种生物分子形式的 ADC，包括抗体片段、纳米抗体、肽类和蛋白质。此外，OBI 的 HYPrOBI® 连接子技术提高了载荷的偶联效率，降低了聚集倾向，并延长了 ADC 产品的半衰期。ThiOBI 克服了传统半胱氨酸 ADC 的局限，并在多项体内研究中实现了更优的抗肿瘤活性和稳定性。GlycOBI®、EndoSymeOBI®、ThiOBI®、HYPrOBI® 和 GlycOBI DUO® 为 OBI 的注册商标。Obrion™ 为正在申请注册的商标。前瞻性声明本新闻稿中非历史事实的陈述属于《1995 年私人证券诉讼改革法》所定义的前瞻性声明。此类前瞻性声明包括但不限于关于未来临床试验、试验结果及其时间安排的陈述。相关风险因素已在 OBI Pharma 的报告和演示材料中不时披露，包括其向台湾证券期货局提交的文件。公司联系人:Jukka MuhonenExecutive Director, Business DevelopmentOBI Pharma USA, Inc.1.617.821.0292 jukkamuhonen@obipharma.com来源: OBI Pharma USA, Inc. Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

BRISBANE, AUS, Apr 15, 2026 - (ACN Newswire via SeaPRwire.com) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to provide the latest progress update on the Graphene Aluminium-Ion Battery technology ("G+A CELLS") being developed by GMG and the University of Queensland ("UQ") under a Joint Development Agreement with Rio Tinto, one of the world's largest metals and mining groups, and with the support of the Battery Innovation Center of Indiana ("BIC") in the United States of America.The GMG G+A CELLS have now demonstrated superior performance characteristics when compared to a representative market leading ultra-fast charging batteries, the Lithium Titanate Oxide ("LTO") batteries, which can be sold at a premium price of up to US$1200/kWh.1Figure 1 shows the current energy density of G+A CELLS, based on BIC testing, and shows the doubling in performance (26 to 49 Wh/kg) since the previous announcement in December 20252 and in comparison, to a representative market leading fast charging high power LTO batteries.Figure 1: Increase in Energy Density for G+A CELLS since December '25 UpdateTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/292641_figure1.jpgFigure 2 shows the charge and discharge curves for the G+A CELLS when charged in 6 minutes (10C) and 60 minutes (1C). The energy density of the cells for the G+A CELLS when charged in 60 minutes (1C) is now 101 Wh/kg when charging to 100% State of Charge (SOC) which is an increase from 58 Wh/kg from the previous update. This shows the G+A CELLS have a nominal voltage of approximately 3.2 Volts (an increase from 3.0 Volts in the previous update). The G+A CELLS maintained performance over hundreds of cycles at 6-minute fast charging rate (10C).Figure 2: Battery performance curves of G+A CELLS at 60 min and 6min charge (1C & 10C)To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/292641_9a72ca9bb4963a29_001full.jpgBob Galyen, GMG Non-Executive Director and former CTO of CATL - the largest battery manufacturer in the world, commented: "With the possibility of charging from empty to full in around six minutes, this chemistry fundamentally changes how designers can think about electric vehicles, consumer electronics, and stationary storage. Instead of planning around long charge stops with large packs, engineers can optimise for rapid energy turnaround, with higher power, and safer, with GMG's battery made from abundant raw materials. Lithium-ion will remain a key part of the energy landscape for years to come, but its limitations in fast charging, temperature tolerance, and critical-mineral supply are increasingly evident. By leveraging aluminium and graphene, the GMG team is demonstrating a pathway to reduce reliance on traditional lithium-based systems and or combinatorial systems with multiple battery technologies while delivering step-change improvements in charge time and power density. This is not an incremental tweak to existing cells - it is a new platform that can open markets and use cases that were previously uneconomic or impractical. The companies that adapt quickest to this shift will lead the next wave of electrification, and GMG intends to be at the centre of that transition with graphene aluminium-ion technology."Standard commercial Lithium Nickel Manganese Cobalt ("LNMC") and Lithium Iron Phosphate ("LFP") battery cells for electric vehicles and stationary storage are NOT designed for continuous 6-minute charging (10C); typical recommended charge rates are ≤1 hour (1C), often 2 hours (0.5C), with only limited fast charge operation. Only specialized high-power cell designs like LTO battery cells can tolerate charge rates of 6 minutes (10C).3GMG has now developed a completely new hybrid electrolyte that is chloride free and non-corrosive, unlike common aluminium battery electrolytes, along with a complex cathode and anode technology that enables very stable fast charging over hundreds of cycles. The substrate for both the cathode and anode in the G+A CELLS is aluminium foil - which provides significant cost and weight savings compared with copper, the substrate material used in most lithium and sodium-ion batteries. GMG's technology does not include the use of lithium or copper. The Company has submitted an additional patent application covering these new developments.GMG believes that it has significantly met the key target specification requirements for use in heavy mobile equipment, as shown in Figure 3, its main targeted use case, including:- Charging in under 6 minutes;- Energy density > 100 Wh/kg after 1 hour of charging; and- Safe (no Lithium).The next battery development steps include the following activities:- Test and show cycle life up to 10,000 cycles- Test and show ambient temperature impacts- Test and show standard safety testing- Test and show no thermal battery management system needed Figure 3: G+A CELLS Battery Use Case - heavy mobile equipmentTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/292641_figure3.jpgCraig Nicol, GMG Managing Director and CEO, commented: "This is a significant step up from where we were at with battery performance in December 2025 and we see the required performance for our targeted use case being largely met - which means we can start to put together the next stages of the battery maturation program - including partnerships and manufacturing plans."GMG management believes that the G+A CELLS can eventually achieve over 160 Wh/kg when charged in 1 hour, and over 80 Wh/kg when charged in 6 minutes with further development of the cathode, anode, electrolyte and component weights.Figure 4 shows the latest G+A CELLS in pouch format:Figure 4: Current Multi-Layer G+A CELLTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/292641_figure4.jpgBattery Technology Readiness LevelThe battery technology readiness level ("BTRL") of the G+A CELLS remains at Level 4, whilst significantly progressed through this level as shown in Figure 5. GMG is currently in the process of completing the optimization of the electrochemical behaviour for the pouch cells via ongoing laboratory experimentation. Through collaboration with BIC, it is anticipated that the battery technology readiness will ultimately progress to BTRL 7 and 8 since the equipment and processes needed to produce the G+A CELLS are the same as those employed to make Lithium-Ion Batteries, though no definitive timeline for achievement can be provided at this time.Figure 5: Battery Technology Readiness Level (BTRL)To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/292641_9a72ca9bb4963a29_004full.jpgThe Company is confident it can meet the overall timeline, as seen in Figure 6, of its battery cell roadmap that calls for testing of cells with customers in 2026 and small commercial production with support of various partners, including BIC, in 2027.Figure 6: Battery Cell RoadmapTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/292641_9a72ca9bb4963a29_005full.jpgNext Steps Toward Commercialisation & Market ApplicationsJack Perkowski, GMG Non-Executive Chairman and Director, commented: "I am extremely proud that GMG has progressed its battery to this stage - the Company is getting very close to final commercialisation steps. We look forward to providing further updates as GMG progresses the development of its battery technology."The Company continues to see a broad range of potential applications for a completed G+A CELLS - utilising its ultra-high power-density and economic energy density characteristics. Along with Rio Tinto, a range of global companies have confidentially expressed their interest in working with GMG in the following vertical sectors:Figure 7: Market ApplicationsTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/292641_9a72ca9bb4963a29_006full.jpgCurrently, GMG believes it will use a plastic battery pack design, similar to Figure 8, to hold the battery pouch cells - reducing the weight, cost and complexity relative to using a metal case. Using a plastic battery pack is possible for two main reasons - GMG believes that its battery will not require a thermal management system or the fireproofing precautions provided by the metal case in a lithium-ion battery. Using plastic will increase the comparative energy density of G+A CELL packs when compared to lithium-ion batteries.Figure 8: Expected Battery Pack for GMG's G+A CELLS Pouch FormatTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/292641_9a72ca9bb4963a29_007full.jpgComparison and Market Review: LTO Batteries As shown in Figure 9 below, the performance of GMG's G+A CELL technology is already very similar to representative LTO batteries.Figure 9: Comparison of GMG's G+A CELLS to Lithium Titanate Oxide (LTO) BatteryTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/292641_figure9.jpg LTO batteries are sold at a premium to LFP and LNMC batteries, which are the main chemistries used in electric vehicles and energy storage systems, and are also widely used in other electronic applications due to their high performance and long cycle life. The material and manufacturing costs for G+A CELLS are expected to be similar to, or less than, the cost to manufacture standard lithium-ion batteries, but substantially lower than the costs to produce LTO batteries.LTO batteries have energy density ranging from 50 - 80 Wh/kg.6 The LTO product is sold globally for use in many applications — with a total of US$5.67 billion sales per annum in 2025. Sales of LTO batteries are expected to grow at 16.9% per annum to an estimated US$ 12.5 billion by 2030. The major manufacturers of LTO batteries include Toshiba, Gree, Microvast and CATL.Further details on applications for the LTO battery from Mordor Intelligence7 are described below. In many of the use cases for LTO batteries, GMG believes that its G+A CELLS can be substituted at a substantially lower cost.Commercial Vehicles: Automotive, primarily buses, refuse trucks, and drayage tractors rather than passenger cars, is the largest user of LTO batteries. Fleets realize five-year total-cost-of-ownership parity once fuel savings and lower maintenance offset higher upfront prices.Fast-charging Electric Buses and Trucks: Transit authorities need battery systems that accept repeated high-power "opportunity charges" during short layovers. LTO cells replenish 80% capacity in roughly five minutes, allowing operators to shrink fleet size without sacrificing route frequency. U.S. Low-No Emission Bus grants earmark more than US$1.5 billion per year, with bid specifications that explicitly reference rapid-charge capability. Parallel subsidy programs in China reimburse up to CNY 80,000 (US$ 11,396) per new-energy bus, accelerating volume deployment in provincial capitals.Hybrid and BEV: Regenerative braking and high-C-rate acceleration favour the use of LTO batteries. Use in fast-charge EV stations is growing rapidly as ride-hailing fleets adopt swap-ready models.Stationary Storage: Utility-scale batteries now cycle multiple times per day for frequency regulation, peak shaving, and voltage support. Energy-storage-system integrators adopt LTO batteries for grid-frequency response where state-of-charge swings are shallow but frequent.Industrial Robotics: LTO batteries are used in continuous-duty forklifts that require partial charges during operator breaks.Aerospace and Defense: Unmanned aerial vehicles, missile auxiliaries, and soldier-worn power banks operating from -40 °C to +60 °C ambient.5-minute Battery-Swap Stations: Battery-as-a-service platforms require ultra-fast turnaround and high cycle life. CATL confirmed plans to install 1,000 swap stations in 2025 and 30,000-40,000 by 2030, each requiring packs that tolerate thousands of rapid exchanges without degradation.Sub-10 kWh Packs: Cordless construction tools, autonomous ground vehicles, and medical carts select LTO batteries to bypass daily pack swaps.12V starter replacement to Lead acid: GMG's G+A CELLS battery technology would be a viable 12 V starter-battery replacement for lead-acid, offering lower weight, longer cycle life, good low-temperature performance and improved cold-cranking capability, together with excellent tolerance to storage at 0% state of charge. In suitable system designs, the chemistry's stable voltage behaviour can also reduce balancing requirements and simplify battery management, helping to lower overall system cost.Lifecycle Procurement Preference: Many government procurement frameworks now weigh lifecycle reliability higher than purchase price. For example, New Mexico awarded a US$ 400 million bus electrification contract that included stringent thermal-runaway resistance metrics. Europe's Clean Industrial Deal allocates capital for storage technologies that stabilize renewables, aligning well with LTO batteries' fast-response profile.Cylindrical Cells: accounted for 37.7% of LTO battery sales in 2024 as entrenched production lines and robust steel casings satisfied heavy-duty demand. Pouch designs address aerospace weight requirements and constrained dashboards in autonomous robots.Summary of Important Milestones for GMG's G+A CELLS Development: MonthImportant Milestones in the Development of the Graphene Aluminium Ion BatteryMay 2020GMG and UQ win Australian Research Council grant for Graphene battery developmenthttps://graphenemg.com/gmg-and-uq-wins-australian-research-council-grant-for-graphene-aluminium-ion-battery-development/Apr 2021The University of Queensland and GMG kick off coin cell battery development projecthttps://graphenemg.com/gmg-the-university-of-queensland-research-uni-quest-kick-off-the-graphene-enhanced-aluminium-ion-battery-development-project/May 2021Graphene aluminium-ion battery performance data - Energy Density and Power Densityhttps://graphenemg.com/gmg-graphene-aluminium-ion-battery-performance-data/Jun 2021Graphene aluminium-ion battery performance data - Cycle Lifehttps://graphenemg.com/graphene-aluminium-ion-battery-performance-data/Jun 2021Significant potential battery customer market response to launch of batteryhttps://graphenemg.com/gmg-graphene-aluminium-ion-battery-progress-update/Jul 2021Investment decision for coin cell battery development centrehttps://graphenemg.com/gmg-battery-pilot-plant-investment/Oct 2021Construction starts for coin cell battery development centrehttps://graphenemg.com/construction-battery-pilotplant/Oct 2021Bosch Australia Manufacturing Solutions and GMG sign Letter of Intenthttps://graphenemg.com/gmg-and-bosch-sign-collaboration-arrangement-for-bosch-to-design-and-deliver-gmgs-graphene-aluminium-ion-battery-manufacturing-plant/Dec 2021Commencement coin cell battery development centrehttps://graphenemg.com/battery-pilot-plant/Dec 2021Initial coin cell batteries sent for customer feedbackhttps://graphenemg.com/graphene-aluminium-battery-customers-prototypes/Mar 2022Initial factory acceptance testing of semi-automated prototype battery cell assembly equipmenthttps://graphenemg.com/gmg-announces-initial-factory-acceptance-testing-of-semi-automated-prototype-battery-cell-assembly-equipment/Mar 2022Wood Engineering and GMG Sign a Letter of Intenthttps://graphenemg.com/gmg-and-wood-agree-collaboration-arrangement-for-wood-to-engineer-and-deliver-major-graphene-manufacturing-expansion-projects/May 2022Rio Tinto and GMG sign Letter of Intenthttps://graphenemg.com/gmg-riotinto-energysavings-battery/Jun 2022Commissioning of Pouch Cell Equipmenthttps://graphenemg.com/gmg-manufactures-first-pouch-cell/Jun 2022Bob Galyen, former chief technology officer of CATL, joins GMG technical advisory committee.https://graphenemg.com/gmg-technical-advisory-committee-leadership-team-additions-and-cfo-change/Aug 2022Investment decision for Phase 1 modular Graphene Production Planthttps://graphenemg.com/gmg-announces-phase-1-expansion-project-to-graphene-manufacturing-facility-for-energy-saving-products-and-batteries/Oct 2022Significant battery performance, cell and graphene production improvementshttps://graphenemg.com/gmgs-battery-update-significant-battery-performance-cell-and-graphene-production-improvements/Dec 2022Investment of $600k Battery Development Centrehttps://graphenemg.com/gmg-invests-au-600000-to-accelerate-battery-pouch-cell-customer-testing-development-in-2023/Feb 2023Australian Government Approval (AICIS) for production and sale of batteries.https://graphenemg.com/gmg-receives-regulatory-approval-to-enable-significant-commercial-sales/May 2023Battery Joint Development Agreement with Rio Tinto signedhttps://graphenemg.com/gmg-announces-battery-joint-development-agreement-with-rio-tinto/May 2023Battery Technology Readiness Level (BRTL) 2-3 reachedhttps://graphenemg.com/gmg-announces-battery-team-and-related-updates/May 2023Decision to switch to develop Pouch Cells (instead of Coin Cells)https://graphenemg.com/gmg-announces-battery-team-and-related-updates/Jul 2023Bob Galyen former chief technology officer of CATL joins GMG board of Directorshttps://graphenemg.com/graphene-manufacturing-group-appoints-former-chief-technology-officer-of-catl-limited-to-its-board-of-directors/Sep 2023Battery Pouch Cell Prototypes Multilayered Auto-Stacker Demonstrationhttps://graphenemg.com/gmg-graphene-aluminium-ion-battery-pouch-cell-prototypes-multilayered-auto-stacker-demonstration/Sep 2023Reaching 500 mAh capacity batteryhttps://graphenemg.com/gmg-achieves-500mah-graphene-aluminium-ion-battery-prototype-in-pouch-cell-format/Sep 2023Battery Technology Readiness Level (BRTL) 4 reachedhttps://graphenemg.com/gmg-achieves-500mah-graphene-aluminium-ion-battery-prototype-in-pouch-cell-format/Nov 2023Rio Tinto and GMG Partnership Video Launchedhttps://graphenemg.com/rio-tinto-gmg-battery-partnership-video-launch/Dec 2023Commissioning of modular Graphene Production Planthttps://graphenemg.com/graphene-manufacturing-group-commissions-modular-graphene-production-plant/Feb 20241000 mAh Capacity Reachedhttps://graphenemg.com/gmgs-graphene-aluminium-ion-battery-1000-mah-capacity-reached-and-next-steps-toward-commercialisation/Mar 2024Graphene Manufacturing Group Secures AU$2 million Funding Grant from Queensland Government for Battery Pilot Planthttps://graphenemg.com/graphene-manufacturing-group-secures-au2-million-funding-grant-from-queensland-government-for-battery-pilot-plant/Aug 2024GMG's Graphene Aluminium-Ion Battery: Progress Update and Next Steps Toward Commercialisationhttps://graphenemg.com/gmgs-graphene-aluminium-ion-battery-progress-update-and-next-steps-toward-commercialisation/Mar 2025GMG's Graphene Aluminium-Ion Battery: Collaboration with World Leading USA Battery Innovation Centre and Next Steps Toward Commercialisationhttps://graphenemg.com/gmgs-graphene-aluminium-ion-battery-collaboration-with-world-leading-usa-battery-innovation-centre-and-next-steps-toward-commercialisation/Dec 2025GMG Unveils Graphene Aluminium-Ion Battery that Fully Charges in 6 minuteshttps://graphenemg.com/gmg-unveils-graphene-aluminium-ion-battery-that-fully-charges-in-6-minutes/ About BIC:BIC is a collaborative initiative designed to incorporate leadership from renowned universities, government agencies, and commercial enterprises. BIC is a public-private partnership and a not-for-profit organization focusing on the rapid development, testing and commercialization of safe, reliable and lightweight energy storage systems for defense and commercial customers. BIC is a unique organization that has been leading battery cell development for world leading battery companies for over 10 years and has carried out over 500 battery development projects.About GMG:GMG is an Australian based clean-technology company which develops, makes and sells energy saving and energy storage solutions, enabled by graphene manufactured via in house production process. GMG uses its own proprietary production process to decompose natural gas (i.e. methane) into its natural elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean-technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has initially focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy-saving coating) which is now being marketed into other applications including electronic heat sinks, industrial process plants and data centres. Another product GMG has developed is the graphene lubricant additive focused on saving liquid fuels initially for diesel engines.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries"). GMG has also developed a graphene additive slurry that is aimed to improve the performance of lithium-ion batteries.GMG's 4 critical business objectives are:Produce Graphene and improve/scale cell production processesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041www.graphenemg.comNeither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking StatementsThis news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements regarding the pricing of LTO batteries, expectations for GMG G+AI batteries to achieve specification requirements for heavy mobile equipment, the lower cost to produce GMG G+AI batteries, expectations for GMG G+AI batteries in respect of charging time, stability, energy density, life cycle, safety, thermal runway risk and the need for a thermal management system when development is completed, that the new hybrid electrolyte is chloride free and non-corrosive, that the cathode and anode technology employed enables very fast and stable charging, that GMG G+AI batteries provide significant cost and weight savings relative to copper, that G+AI batteries can achieve over 150 Wh/kg charged over 1 hour and 75 Wh/kg when charged over 6 minutes following further development of cathode, anode, electrolyte and component weights, that G+AI batteries will progress to BTRL 7 and 8, that the timeline for the battery cell roadmap is achievable, that a range of global companies in a variety of industries will be interested in working with GMG, that the battery pack design will be plastic and which offers weight, cost and complexity advantages to a metal case and increased energy density, expectations for the lack of a thermal management system or fireproofing precautions, expectations for material and manufacturing costs, expectations for sales of LTO batteries, expectations for G+AI batteries being substitutable for LTO batteries at lower cost, expectations that G+AI batteries are viable 12V starter battery replacements and the rationale therefor and the advantages of pouch design for aerospace weight requirements and constrained dashboards of autonomous robots.Such forward-looking statements are based on a number of assumptions of management, including, without limitation, assumptions that GMG G+AI batteries can be produced at lower cost, as to charging time, energy density, life cycle, safety, thermal runway risk and the need for a thermal management system for G+AI batteries, the speed and stability of charging, that G+AI batteries will progress to BTRL 7 and 8, that a range of global companies in a variety of industries will be interested in working with GMG, that the battery pack design will be plastic and offer weight, cost and complexity advantages to a metal case and increased energy density, that the service agreement with the BIC will enable the Company to optimize its cell design and battery manufacturing equipment, and that the Company will be able to meet its overall timeline on the battery cell roadmap. Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: that GMG G+AI batteries cannot be produced at lower cost, or any of the assumptions as to charging time, energy density, life cycle, safety, thermal runway risk and the need for a thermal management system for G+AI batteries can not be achieved, G+AI batteries do not offer expected speed and stability of charging, that G+AI batteries will not progress to BTRL 7 and 8, that a range of global companies in a variety of industries will not be interested in working with GMG, that the battery pack design will not be plastic and not offer weight, cost and complexity advantages to a metal case and increased energy density, that the Company will not be able to optimize the electrochemical behaviour of the pouch cell through laboratory experimentation or at all, that the Company will not be able to meet its overall timeline on the battery cell roadmap, that the service agreement with the BIC will not enable the Company to optimize its cell design and battery manufacturing equipment and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated November 04, 2025 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.1 https://www.ritarpower.com/industry_information/The-Price-of-50-kWh-Lithium-Ion-Batteries-A-Comprehensive-Analysis_297.html#:~:text=Lithium%20Titanate%20(LTO)%20Batteries%3A,cost%20between%20%2440%2C000%20and%20%2460%2C000.2 https://graphenemg.com/gmg-unveils-graphene-aluminium-ion-battery-that-fully-charges-in-6-minutes/3 https://findingspress.org/article/21459-impact-of-charging-rates-on-electric-vehicle-batt4 High-power type cells | SCiB™ Rechargeable battery | Toshiba5 https://www.ritarpower.com/industry_information/The-Price-of-50-kWh-Lithium-Ion-Batteries-A-Comprehensive-Analysis_297.html#:~:text=Lithium%20Titanate%20(LTO)%20Batteries%3A,cost%20between%20%2440%2C000%20and%20%2460%2C000.6 https://www.grepow.com/blog/battery-energy-density.html7 Lithium Titanate Oxide Battery Market Size, Share & 2030 Growth Trends ReportTo view the source version of this press release, please visit https://www.newsfilecorp.com/release/292641 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

TAIPEI, TW, Apr 15, 2026 - (ACN Newswire via SeaPRwire.com) - OBI Pharma, Inc. (TPEx:4174.TWO) today announced its presence at AACR 2026, highlighted by ten poster presentations, showcasing the transformative potential of the GlycOBI® platform. Conventional ADCs often face limitations due to random conjugation, resulting in heterogeneous Drug-to-Antibody Ratios (DAR), suboptimal stability, and narrow therapeutic windows. In contrast, the OBI site-specific glycan-based technology enables a highly homogeneous DAR, translating into improved PK/PD profiles, and reduced off-target toxicity, as demonstrated by OBI's lead programs, OBI-902 and OBI-904.We are further advancing precision oncology through our next-generation bispecific (OBI-201) and bispecific, dual-payload (OBI-221) ADCs. These "biology - driven" molecules are designed to overcome tumor heterogeneity and multi-drug resistance-key challenges in current cancer treatment. By incorporating both the GlycOBI® and GlycOBI DUO® platforms, OBI is developing novel and differentiated therapeutics addressing the unmet medical need for patients with difficult-to-treat solid tumors. Additionally, OBI's robust ADC conjugation platform has proven to consistently deliver product quality and scalability, while enabling expansion into next-generation modalities, including degrader-antibody conjugates (DACs).These data will be presented at the American Association of Cancer Research (AACR) Annual Meeting from April 17 to 22, 2026 in San Diego, CA. (USA)."At OBI, we make better ADCs," said Dr. Ya-Chi Chen, Chief Scientific Officer OBI Pharma. "Our goal is to deliver therapies that not only target tumors more effectively and precisely, but also reduce side effects, giving patients potentially life-changing treatment options."Monday, April 20, 2026 (9:00 AM - 12:00 PM)Title: Overcoming Resistance with OBI-902: Preclinical Evaluation of a Next-Generation TROP2 ADC1Authors: Ren-Yu Hsu, Chi-Huan Lu, Chi-Sheng Shia, Jing-Rong Huang, Hsin-Shan Wu, Lu-Tzu Chen, Jhih-Jie Yang, Tzu-Min Yen, Jyy-Shiuan Tu, Yu-Hsuan Tsao, Ya-Chi Chen. OBI Pharma, Inc, Taipei, TaiwanSession Title: PO. ET07.01 - Quantitative Pharmacology and Translational ModelingLocation: Poster Section 17Poster Board Number: 6Abstract Presentation Number: 1818Title: OBI-904, a Next-Generation Nectin-4-Targeting Exatecan ADC, Demonstrates Enhanced Cytotoxicity and Overcomes Enfortumab Vedotin Resistance2Authors :Yuan-Liang Wang, Chi-Huan Lu, Woan-Eng Chan, Shin-Jin Lin, Ting-Yu Chang, Hong-Syuan Lin, Wei-Jhen Huang, Ya-Chi Chen. OBI Pharma, Inc, Taipei, TaiwanSession Title: PO.ET02.02 - Antibody-Drug Conjugates and Linker Engineering 2Location: Poster Section 13Poster Board Number: 26Abstract Presentation Number: 1729Title: OBI-904, a Glycan-based Site specific Nectin-4-Targeted ADC, Demonstrates Potent and Durable Antitumor Activity with an Improved PK Profile and Overcoming EV-Resistance in Non-Clinical Studies3Authors: Chi-Huan Lu, Ren-Yu Hsu, Jing-Jie Ciou, Tzu Min Yen, Jyy-Shiuan Tu, Yu-Hsuan Tsao, Jing-Rong Huang, Ya-Chi Chen. OBI Pharma, Inc., Taipei, TaiwanSession Title: PO.ET07.01 - Quantitative Pharmacology and Translational ModelingLocation: Poster Section 17Poster Board Number: 7Abstract Presentation Number: 1819Title: The MET/HER3 Antibody-Drug Conjugate with Dual Payload: A Dual-Target Approach to Eliminate Tumor Escape Mechanisms5Authors: Yuan-Liang Wang, Chi-Huan Lu, Woan-Eng Chan, Ting-Yu Chang, Hong-Syuan Lin, Cheng-Yen Wei, Shin-Jin Lin, Lu-Tzu Lu, Meng-Hsin Liu, Wei-Jhen Huang, Ya-Chi Chen. OBI Pharma, Inc., Taipei, TaiwanSession Title: PO.CL.0705 - Targeted Antigen Therapies and ImmunityLocation: Poster Section 49Poster Board Number: 17Abstract Presentation Number: 2665Title: Guide-effector bsADCs: Driving co-endocytosis for enhanced payload delivery6Authors: Wei-Jhen Huang, Woan Eng Chan, Meng-Hsin Liu, Yueh Chin Wu, Ya-Chi Chen .OBI Pharma, Inc., Taipei, TaiwanSession Title: PO.ET02.02 - Antibody-Drug Conjugates and Linker Engineering 2Location: Poster Section 13Poster Board Number : 27Abstract Presentation Number: 1730Title: Hydrophilicity-Enhanced Linker Technology Enables Site-Specific Degrader-Antibody Conjugates with Improved Stability and Enhanced Activity7Authors: Yu-Hung Chen, Wei-Chien Tang, Chi-Dian Lu, Hung-Yi Lin, Wei-Jhen Huang, Nan-Hsuan Wang, Ya-Chi Chen, Teng-Yi Huang. OBI Pharma, Inc., Taipei, TaiwanSession Title: PO.ET02.02 - Antibody-Drug Conjugates and Linker Engineering 2Location: Poster Section 13Poster Board Number: 28Abstract Presentation Number: 1731Title: Cell-based payload release highlights design, site, and cell-dependent ratio shifts in dual-payload ADCs8Authors: Nan-Hsuan Wang, Wei-Han Lee, Evelyn He, Li Chuan Huang, Yu-Chao Huang, David Teng-Yi Huang, Ya-Chi Chen. OBI Pharma, Inc, Taipei, TaiwanSession Title: PO.CH01.06 - Antibodies, Antibody-Drug Conjugates, and Nucleic AcidsLocation: Poster Section 38Poster Board Number: 5Abstract Presentation Number: 2397Monday, April 20, 2026 (2:00 PM - 5:00 PM)Title:TROP2 Upregulation and Interaction with HER2 Mediate Trastuzumab Resistance4Authors: Yuan-Liang Wang, Chi-Huan Lu, Cheng-Yen Wei, Jye-Yu Huang, Woan-Eng Chan, Lu-Tzu Chen, Ya-Chi Chen. OBI Pharma, Inc., Taipei, TaiwanSession Title: PO.ET03.06 Drug Resistance 1: Antibodies and ADCsLocation: Poster Section 12Poster Board Number: 18Abstract Presentation Number: 2972Tuesday, April 21, 2026 (9:00 AM - 12:00 PM)Title: Glycan-based site specific ADC Achieves Sustained Tumor Control through Improved Payload Delivery and Immune Activation9Authors: Liu Chih-Chun, Tsai Yi-Chien, Huang Jing-Rong, Lo Fei-Yun, Pei Yu, Hsu Ren-Yu, Tu Tzu-Hsuan, Chen Ya-Chi. OBI Pharma, Inc, Taipei, TaiwanSession Title: PO.IM02.04 - Adaptive Immunity in CancerLocation: Poster Section 6Poster Board Number: 2Abstract Presentation Number: 4234Title: Advancing ADC therapeutics with next-generation site-specific glycan conjugation and dual-payload flexibility10Authors: Wei-Chien Tang, Yu-Hung Chen, Chih-Kang Chang, Ting-Wei Liu, Hung-Yi Lin, Wei-Jhen Huang, Chi-Huan Lu, Ren-Yu Hsu, Nan-Hsuan Wang, Ya-Chi Chen,Teng-Yi Huang. OBI Pharma, Inc, Taipei, TaiwanSession Title: PO.ET02.03 - Antibody-Drug Conjugates and Linker Engineering 3Location: Poster Section 12Poster Board Number: 1Abstract Presentation Number: 4423The e-posters will be available for browsing at the AACR virtual meeting platform beginning at 12:00 PM PT on April 17, as well as on the OBI Pharma website (www.obipharma.com) beginning on April 18.1 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/45832 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/53853 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/45884 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/50305 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/40516 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/54007 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/54018 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/64749 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/131110 AACR Annual Meeting 2026 Abstracts online https://www.abstractsonline.com/pp8/#!/21436/presentation/5403About OBI PharmaOBI Pharma is a clinical-stage global oncology company established in 2002 and headquartered in Taiwan. Together with its subsidiary OBI Pharma USA, Inc., the company is dedicated to developing innovative cancer therapeutics to provide new treatment options for patients with urgent medical needs.OBI's research efforts center on novel antibody-drug conjugates (ADC). Through its patented next-generation conjugation technology platform, Obrion™, OBI has established diverse ADC design modalities. The platform integrates proprietary conjugation and linker technologies, including GlycOBI®, GlycOBI DUO®, EndoSymeOBI®, HYPrOBI®, and the novel irreversible cysteine-conjugation technology ThiOBI® , to advance next-generation ADC solutions. OBI has developed a next-generation suite of ADC programs. These include monospecific ADCs such as OBI-902 (TROP2), which is under Ph1 clinical evaluation, and OBI-904 (Nectin-4); a bispecific single-payload ADC, OBI-201 (HER2 x TROP2); and a bispecific dual-payload ADC, OBI-221 (cMET x HER3). To broaden the applicability of the HYPrOBI® linker technology, OBI has further developed the ThiOBI® technology to enable irreversible cysteine-based conjugation. In addition to its ADC programs, OBI's assets include OBI-3424, a first-in-class AKR1C3-targeted small-molecule prodrug that selectively releases a potent DNA-alkylating agent in the presence of the aldo-keto reductase 1C3 enzyme, which is highly expressed in certain tumors. Additional information can be found at www.obipharma.com.About OBI-902 and OBI-992OBI-902 is a TROP2-targeted antibody-drug conjugate (ADC) that carries a potent topoisomerase I inhibitor payload to kill tumor cells with a drug-antibody ratio (DAR) of 4. TROP2 is highly expressed in a variety of solid tumors such as breast, lung, biliary, bile duct (cholangiocarcinoma), ovarian, gastric, and many other cancer types, rendering it an ideal target for cancer therapy.OBI-902 is a novel site-specific glycan-conjugated ADC using OBI's proprietary GlycOBI® platform, which provides improved stability and enhanced hydrophilicity. OBI-902 demonstrated remarkable antitumor efficacy across multiple tumors, including NSCLC, triple-negative breast cancer (TNBC), and gastric cancer, improved pharmacokinetic characteristics, and a favorable safety profile in various animal models. The IND of OBI-902 was cleared by the United States Food and Drug Administration (US FDA) on April 30, 2025, received Orphan Drug Designation (ODD) from the US FDA for cholangiocarcinoma on Nov. 16, 2025, and gastric cancer (GC), including gastroesophageal junction cancer (GEJC) on December 5, 2025.The Phase 1/2 Study (NCT07124117) is ongoing, with completion of the Phase 1a portion targeted for 1H 2027.OBI-992 is a TROP2-targeted antibody-drug conjugate (ADC) that carries a potent topoisomerase I inhibitor payload with drug-to-antibody ratio of 4 (DAR 4) via a cysteine conjugated, hydrophilic and enzyme-cleavable linker. OBI-992 remains stable in circulation and delivers this cytotoxic payload to TROP2-expressing tumor cells, leading to tumor cell death while avoiding off-target toxicities.The US FDA cleared the IND application for OBI-992 in Jan 2024 and subsequently granted Orphan Drug Designation for the treatment of gastric cancer, including GEJC in Aug 2024. The Phase 1/2 Study (NCT06480240) has reached the putative Recommended Phase 2 Dose (pRP2D) and Phase I completion is targeted for 1H 2027.Since December 2021, OBI has been granted by Biosion, Inc. (www.biosion.com) an exclusive license to a TROP2 targeting antibody amino acid sequence in all jurisdictions except Mainland China, Hong Kong and Macau. Biosion holds exclusive rights to that antibody sequence in Mainland China, Hong Kong and Macau. OBI holds commercial rights to OBI-992 and OBI-902 in all jurisdictions except Mainland China, Hong Kong and Macau, while Biosion holds commercial rights to OBI-992 and OBI-902 in Mainland China, Hong Kong and Macau.About OBI-904OBI-904 is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody specifically targeting Nectin-4 (Nectin cell adhesion molecule 4), linked to a potent topoisomerase I inhibitor payload with Drug-to-Antibody Ratio of 8 (DAR8) through OBI's proprietary GlycOBI® ADC enabling technologies, powered by a dual-function enzyme, EndoSymeOBI®, and a novel linker, HYPrOBI®. It is a potentially first-in-class and best-in-class glycan-based ADC designed to target multiple cancer types that express Nectin-4. Antitumor activity has been shown across several animal disease models, including HNSCC, CRC, TNBC, cervical and sarcoma cancers; OBI-904 has demonstrated a favorable safety profile in a repeat dose toxicity study in monkeys, and is now in the pre-IND stage of development.About OBI-201OBI-201 is a TROP2 x HER2 bispecific ADC generated by OBI GlycOBI® ADC enabling technologies conjugated with a topoisomerase I inhibitor. Notably, OBI is the first to demonstrate that HER2 and TROP2 can interact and form a protein complex on the cell surface-a groundbreaking discovery facilitated through collaboration with a specialized AI drug discovery partner. OBI-201 offers several advantages over mono-specific TROP2 or HER2 ADCs. By targeting both antigens, it broadens tumor coverage, especially in cancers with heterogeneous or low expression of either target. Dual targeting can enhance tumor selectivity, binding avidity, and internalization, improving payload delivery to cancer cells while potentially reducing toxicity to normal cells. OBI-201 may overcome resistance associated with downregulation of targets after treatment by certain monospecific ADCs.Animal studies revealed that OBI-201 demonstrated significantly superior anti-tumor activity compared to single-target ADCs in drug-resistant breast cancer models with extremely low HER2 expression. OBI-201 was able to sustain tumor growth suppression, indicating its potential to overcome multiple drug-resistance mechanisms. OBI-201 is a next-generation bispecific ADC poised to break through the limitations of single-target ADCs, potentially offering patients a more comprehensive and durable treatment option.About OBI-221OBI-221 is a Bispecific-Dual Payload ADC (BsDpADC), generated by OBI GlycOBI DUO® technologies, targeting cMET and HER3, conjugated with dual payload of MMAE and topoisomerase I inhibitor.In clinical practice, EGFR-targeted therapies have become a key strategy for treating non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) patients. However, tumors often rapidly develop resistance by upregulating cMET and HER3 that, in turn, sustain tumor growth. Moreover, high expressions of cMET and HER3 have been observed in gastric cancer, head and neck cancer, and various other solid tumors, further underscoring the unmet medical needs.To address this challenge, OBI Pharma leverages its proprietary GlycOBI DUO® platform and HYPrOBI® linker to develop a novel bispecific dual-payload antibody-drug conjugate (BsDpADC)-OBI-221. This therapeutic agent simultaneously targets cMET and HER3 while delivering synergistic cytotoxic agents, effectively combating tumor resistance and heterogeneity. This breakthrough design not only addresses an unmet medical need but also represents a forward-looking strategy for next-generation ADC development.OBI-221 holds meaningful potential to overcome resistance to existing EGFR-targeted therapies, potentially offering patients more targeted treatment options while delivering substantial clinical value.About GlycOBI®OBI has developed a unique glycan-based, site-specific ADC technology (GlycOBI®), designed in a Plug and Play format that is compatible with any antibodies, linkers, and payloads, and supports various drug-antibody ratios (DAR)(up to 16). Powered by OBI's proprietary dual-function enzymatic technology EndoSymeOBI® and its hydrophilic linker technology HYPrOBI®, GlycOBI®, a core component of OBI's Obrion™ ADC technology family, enables the generation of site-specific and homogeneous ADCs through an efficient, scalable and streamlined two-step, one-pot conjugation process under GMP conditions.During the conjugation process, GlycOBI® avoids disrupting the antibody structure and ensures that the resulting ADC retains biophysical characteristics comparable to the native antibody. In addition, OBI's linker technology improves payload conjugation efficiency and reduces the propensity for aggregation or degradation, further supporting a stable and well-controlled ADC manufacturing process. GlycOBI® has overcome limitations commonly associated with traditional ADC approaches and has demonstrated improved antitumor activity and stability in various in vivo studies. Notably, the platform supports the conjugation of both cytotoxic small-molecule inhibitors and highly hydrophobic degraders, expanding its applicability to next-generation modalities such as DACs.About GlycOBI DUO®GlycOBI DUO® is a next-generation dual-payload antibody-drug conjugate (ADC) technology built on the GlycOBI® site-specific conjugation platform and its proprietary enzymatic conjugation strategy. It enables the precise and programmable attachment of two distinct payloads to a single antibody with tunable ratios and supports high DAR ratios, including up to DAR24. By combining complementary mechanisms of action, GlycOBI DUO® is designed to enhance antitumor efficacy, address tumor heterogeneity, and improve the overall therapeutic index, with the potential to overcome resistance mechanisms associated with conventional ADCs-representing a promising advancement in next-generation ADC development.About ThiOBI®OBI has developed a novel irreversible, cysteine conjugation ADC platform (ThiOBI®) with improved stability, which can apply to any antibodies, linkers, and payloads. OBI's proprietary ThiOBI® platform including linker technologies (HYPrOBI®) can generate ADCs in different biomolecular formats, including antibody fragments, nanobodies, peptides, and proteins. Furthermore, OBI's HYPrOBI® linker technology has improved conjugation efficiency of the payload and reduced aggregation propensity and also expanded the half-life of the ADC products. ThiOBI has overcome the limitations of traditional cysteine ADCs and achieved better antitumor activity and stability in various in vivo tests.GlycOBI®, EndoSymeOBI®, ThiOBI®, HYPrOBI®, and GlycOBI DUO® are registered trademarks of OBI. Obrion™ is a trademark under registration.Forward-Looking StatementsStatements included in this press release that are not a description of historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements about future clinical trials, results and the timing of such trials and results. Such risk factors are identified and discussed from time to time in OBI Pharma's reports and presentations, including OBI Pharma's filings with the Taiwan Securities and Futures Bureau.COMPANY CONTACT:Jukka MuhonenExecutive Director, Business DevelopmentOBI Pharma USA, Inc.1.617.821.0292jukkamuhonen@obipharma.comSOURCE: OBI Pharma USA, Inc. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年4月15日 - (亚太商讯 via SeaPRwire.com) - 品创控股有限公司（"品创控股"或"公司"，连同其附属公司统称为"集团"；股份代号：8066）欣然宣布，集团全资附属公司赛博幻境（香港）有限公司（"赛博幻境"）于今日隆重举行《语音 AI 之 Echo 生态战略全球启幕盛典》，正式启动其全球语音 AI 回声生态系统（Echo Ecosystem，"回声生态"）战略，构建从语音数据采集、处理到商业应用的全链路闭环。此举标志着集团在人工智能语音数据服务领域的战略布局迈入全新阶段，为集团深化 AI 业务转型、打造长效增长曲线奠定坚实基础。针对语音数据采集规模、质量与多样性的行业困境，赛博幻境创造性推出区块链游戏与语音数据采集相结合的全新模式。用户参与游戏时，完成指定文本的语音录制任务，既可享受游戏乐趣，亦可获得代币激励。该"游戏化采集"模式，可大规模、高效率获取覆盖不同年龄、地域、口音与情感表达的真人语音数据，为构建多元化声音数据库提供稳定持续的来源。采集完成后，回声平台透过专业清洗、标注与分类处理，将原始语音转化为可直接用于 AI 训练的结构化声音数据库。相关数据库于 AI 数据市场以回声代币交易，供全球开发者及企业采购使用，形成"用户参与采集 — 获取代币激励 — 数据加工处理 — 市场交易流通 — 产业应用赋能"的完整价值链闭环。该模式不仅大幅降低语音 AI 开发门槛，更让数据贡献者、开发者及终端用户共享语音 AI 发展所带来的裨益。"语音 AI 不仅是技术，更是未来数字世界的入口。"赛博幻境首席执行官郭晓鹏先生在盛典上表示，"回声生态致力于构建语音 AI 时代的基础设施，透过去中心化的数据采集网络和开放的声音数据库市场，我们将为全球 AI 开发者提供最丰富、最优质的声音数据资源，推动语音 AI 技术在各行各业的快速落地和应用创新。"当前，人工智能技术加速渗透各行各业，人机对话已成为 AI 应用场景的核心交互方式。语音 AI 技术作为 AI 智能体不可或缺的组成部分，正成为连接人类与数字世界的入口。高品质、多元化的声音数据库是 AI 智能体强化训练的核心基础，语音 AI 技术发展已进入"数据驱动"新阶段，优质声音数据库不仅可显著提升语音合成的情感表现力、语音识别的场景适应性与对话系统的个性化能力，更成为语音 AI 产业发展的核心竞争力与先发优势所在。品创控股锐意推动业务多元化布局，把握数字经济与人工智能产业的蓬勃商机，并凭借前瞻性转型，成功构建"私域电商营运+AI技术服务"双轮驱动的业务架构。本次回声生态全球启动，是集团深化AI业务布局、推动主营业务向AI数据服务转型的关键里程碑。展望未来，集团将以赛博幻境为核心载体，持续深耕语音AI技术研发，拓展生态合作网络，推动技术在智能客服、数字人、元宇宙、智能汽车等前沿领域深度融合；同时深化两大业务协同效应，强化核心竞争力，推动业务高质量发展，把握全球AI产业广阔机遇，致力为股东创造可持续长期回报。图片说明赛博幻境首席执行官郭晓鹏先生讲解去中心化语音网络的价值实现，彰显品创控股推动语音 AI 技术在各行各业的快速落地和应用创新的决心。关于品创控股有限公司品创控股有限公司的使命是妥善运用公司所获得的资本与独特投资机会，为股东提供稳定的优渥收入与获利。品创控股由六个主要事业部门组成，包括智能卡制造服务、电子商务、人工智能、投资服务、资源回收投资与媒体与娱乐投资，主要业务为生产及销售智能卡、提供定制智能卡应用系统、私域电子商务平台营运、人工智能语音技术数据服务、提供财务及管理咨询服务、废旧金属销售及贸易、以及媒体与娱乐行业之投资。公司的总部位于香港，旗下控股公司与投资则遍布大中华地区。关于赛博幻境（香港）有限公司赛博幻境（香港）有限公司是品创控股有限公司的全资子公司，专注于语音人工智能技术的研发与应用。赛博幻境致力于通过创新的生态模式，打造从数据采集、处理到商业落地的全链条语音AI解决方案，助力全球智能语音产业的发展。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年4月15日 - (亚太商讯 via SeaPRwire.com) - 中国领先循环经济产业新消费公司转转集团（下称：转转）近日宣布，其自主研发的AI鉴定产品「AI拍图验真」已在二手奢侈品鉴定领域取得重大突破，鉴定准确率实现了LV包袋鉴定错误率不足万分之一、GUCCI包袋零错误的卓越表现；鉴定效率提升近900倍至「1秒出结果」。集团今年将逐步把AI鉴定拓展至CHANEL、Hermès等热门品牌，并于未来延伸至腕表等其他二手品类，构建全品类AI鉴定矩阵。凭借其顶尖AI鉴定能力及创新业务模式的领先优势，转转同步计划在香港设立国际业务总部，正式开启全球化布局。作为中国头部二手交易平台，转转自2015年成立以来发展迅速，旗下拥有转转、找靓机、红布林等多个知名二手消费品牌。当前中国二手闲置赛道备受资本与市场瞩目，转转亦凭借首创的二手质检「官方验」服务脱颖而出。集团已获包括腾讯、小米、58集团在内的多个知名企业或投资者支持，上一轮融资估值达逾30亿美元（约234亿港元），去年营收总额突破200亿元人民币，拥有超过4亿注册用户、5,000万月活跃用户。 （图为北京「超级转转」二奢仓店）有别于以Carousell、闲鱼等企业为代表的传统C2C模式，转转透过成熟的C2B2C商业模式，以「平台居中、专业鉴定、品质保证」提供差异化平台服务。其首创的「官方验」服务会在对回收商品全方位严格检测后为其提供一份专属的质检报告并公开展示，绝大部分官方验商品，都可享有7天无理由退货、一年平台质保、内陆包邮等增值服务。转转透过标准化质检与售后保障，例如履行「验了再发货」、「不满意可退」、「验错了就赔」等策略，为消费者提供「所见即所得」的优质体验。 （图为转转青岛智能质检中心）技术驱动是转转稳居行业领先地位的核心引擎。转转去年成立了AI事业部，三年内拟投入20亿元人民币研发AI质检、智能匹配等工具。今年初上线的「AI拍图验真」，深度应用于二手奢侈品鉴定领域，系统基于海量真实商品图片数据库与深度学习算法，将传统需时15分钟的人工鉴定大幅压缩至「秒级鉴定」，最快1秒即可出结果，效率提升近900倍;同时在核心包袋品类的鉴定上，更创下错误率不足万分之一的超高准确率（上线至今，LV包袋累计鉴定逾万单，仅错一单，错误率不足万分之一），彻底打破了传统非标品交易及人工鉴定中的标准不一、效率樽颈等难题。转转集团创办人兼行政总裁黄炜表示：「转转集团在过去十年间通过持续的技术创新和战略整合，确立了在中国二手交易市场的领导地位，我们深信领先的技术与质检能力是打破二手交易壁垒的关键。转转致力引领中国的二手消费模式，不断刷新消费者的二手消费体验，我们对即将在香港设立国际业务总部感到振奋，亦是标志着转转从中国市场迈向国际舞台的重要里程碑。」 （图为转转APP内商品AI鉴定信息）关于转转转转集团成立于2015年，是中国领先的循环经济产业新消费公司，旗下拥有转转、找靓机、采货侠、侠客汇、红布林等多个二手电商品牌，业务覆盖手机3C、奢侈品、图书、潮玩等百余种余种品类二手商品交易，在全国布局超过1,100多家线下门店和超过3,000人的上门回收团队，通过人工智能质检技术和创新的C2B2C商业模式，致力解决非标品交易的信任难题，为消费者带来有质价比的二手好物。转转作为全国有履约二手商品交易平台的领导企业，去年已录得超过4亿注册用户、5000万月活跃用户。「技术驱动+平台服务」为核心引擎，转转特设AI事业部，在国立首创二手质检「官方验」服务，并先后自主研发AI估价系统、AI拍图验真等核心技术产品，打造了二奢行业的顶尖AI鉴定能力，为全球知名热门的奢侈品牌包袋品类提供秒级且精准的真伪鉴定，持续引领中国二手交易市场向标准化、数字化迈进。传媒垂询，请联络：转转集团公关部 Alan Wei：weixi@zhuanzhuan.com Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SINGAPORE, Apr 15, 2026 - (ACN Newswire via SeaPRwire.com) - As artificial intelligence adoption accelerates across Southeast Asia, enterprises across the ASEAN region are increasingly establishing structured AI engineering practices to move from experimentation to production-scale deployment.According to Joseph Bosco, Partner Manager, APJ - Prof Services at Databricks, organisations across ASEAN are recognising that sustainable AI adoption depends not only on advanced models but also on robust engineering foundations that ensure reliability, governance and operational scalability.“The early phase of AI adoption focused heavily on experimentation and proofs of concept,” Bosco said. “Across Southeast Asia we are now seeing a shift towards AI engineering practices that prioritise data quality, governance and production readiness.”Markets such as Singapore, Indonesia, Vietnam, Malaysia and Thailand are witnessing strong momentum in enterprise AI adoption as organisations modernise their data infrastructure and invest in advanced analytics capabilities.Industry experts note that AI engineering is becoming a critical discipline that connects AI innovation with enterprise operations. This includes building scalable data pipelines, managing machine learning lifecycle processes and integrating AI systems into business workflows.“Building a model is only one part of the challenge,” Bosco said. “The real work lies in creating reliable data pipelines, managing model lifecycle and embedding AI into operational systems.”Across ASEAN, many enterprises continue to manage complex data environments spanning legacy systems, multiple cloud platforms and software-as-a-service applications. Consolidating these fragmented data sources into unified platforms is increasingly seen as a prerequisite for scaling AI initiatives.Technology partners and consulting firms across the region are responding by developing dedicated AI engineering practices that combine expertise in data engineering, machine learning, generative AI and governance frameworks.These capabilities are already being applied across key sectors including financial services, telecommunications, and manufacturing.Bosco noted that Southeast Asia’s rapidly expanding data economies are creating a particularly dynamic environment for AI engineering talent and innovation.“As organisations across ASEAN continue to invest in data transformation, AI engineering will become an essential capability that enables enterprises to operationalise AI safely and effectively,” he said. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

KUALA LUMPUR, Malaysia, April 14, 2026 - (ACN Newswire via SeaPRwire.com) - Exito Media Concepts today announced the 46th Edition of the Digital Transformation Summit Malaysia 2026, convening on 23rd April 2026 at the Hyatt Regency Kuala Lumpur Midtown. The summit will bring together more than 200 C-Level executives, technology directors, and government leaders to address the strategic and operational imperatives shaping Malaysia's next phase of digital growth.Now in its 46th edition and part of a series spanning 11+ countries, the summit has established itself as one of Asia Pacific's most consequential forums for enterprise technology leadership.The Strategic Context: Malaysia's Digital Economy at a Critical JunctureMalaysia's digital economy is undergoing a structural shift. Driven by targeted government-led initiatives and accelerating enterprise adoption of artificial intelligence, the Internet of Things, and Web 3.0, organizations across every sector are fundamentally reimagining how they operate, compete, and deliver value.The opportunity is significant. Yet the path to enterprise-wide transformation demands more than technology investment — it requires navigating complex cybersecurity environments, integrating legacy infrastructure with modern digital architecture, developing organizational capabilities at pace, and embedding a culture of innovation that sustains long-term resilience. For Malaysia's business leadership, strategic clarity has never been more consequential.The Digital Transformation Summit Malaysia 2026 is designed precisely for this inflection point.Enterprise Transformation in PracticeThe business case for bold digital action is already being written across Malaysia. A leading domestic enterprise recently undertook a comprehensive digital transformation initiative — transitioning to a cloud-first infrastructure supported by advanced data analytics and AI capabilities.The results were measurable and material: automating key operational processes delivered significant gains in efficiency and organizational agility. The concurrent deployment of robust cybersecurity frameworks ensured data integrity and regulatory compliance. Simultaneously, structured workforce upskilling programmes enabled teams to perform with confidence in an evolving technology environment.The outcome: improved business performance, deeper customer engagement, and a materially stronger competitive position within Malaysia's digital economy. It is precisely this calibre of real-world insight that the Summit is built to surface and scale.Event OverviewThe 46th Edition of the Digital Transformation Summit Malaysia 2026 is part of a globally recognized series of events hosted across 11+ countries. This edition will convene more than 200 C-Level Executives, Directors, Heads of Technology, Government leaders, and digital transformation leaders from across industries.Through expert-led keynotes, panel discussions, and real-world case studies, the summit will highlight innovative strategies, emerging technologies, and actionable insights that empower organizations to drive digital growth and operational excellence.Date: 23rd April 2026Time: 09:00 AM to 05:00 PMVenue: Hyatt Regency Kuala Lumpur MidtownWebsite: https://digitransformationsummit.com/malaysia/Summit Agenda: Technology Priorities Shaping 2026Delivered through expert-led keynotes, high-impact panel discussions, and documented case studies, the Summit agenda will address the technology priorities most consequential to enterprise leaders this year:Artificial Intelligence & Machine Learning Embedding intelligent decision-making and automation across core business functions — from supply chain to customer experience to financial operations.Web 3.0 & Emerging Technologies Navigating decentralized innovation and unlocking new digital ecosystems with long-term enterprise relevance.Internet of Things (IoT) Advancing operational connectivity and efficiency across industries through integrated sensor and data infrastructure.Quantum Computing Examining the practical and strategic implications of the next frontier in computational capability.Cybersecurity & Data Protection Strengthening enterprise digital resilience against an increasingly sophisticated and expansive threat landscape.Cloud & Scalable Infrastructure Building the foundational agility, continuity, and scalability demanded by modern enterprise growth.Digital Culture & Transformation Strategy Developing the leadership frameworks and organizational behaviours that sustain transformation well beyond initial implementation.Data-Driven Decision Making Harnessing analytics to convert raw data into competitive intelligence and measurable business outcomes.About Exito Media ConceptsExito — the word for success — is both the name and the operating philosophy of one of the world's most active B2B events and media organizations. Over 16 years, Exito has built a reputation for delivering 240+ conferences annually across technology, digital transformation, cybersecurity, healthcare, and emerging enterprise sectors worldwide.Every Exito event is defined by meticulous agenda curation, access to world-class speaker communities, and a commitment to market-driven insight that translates directly into strategic value for attendees, sponsors, and partners. The result is a global platform trusted by thousands of senior executives to inform their most consequential decisions.Media ContactPrakruthi NayakaMedia and PR Executive, Exito Media ConceptsEmail: prakruthi.nayaka@exito-e.comWebsite: https://digitransformationsummit.com/malaysia/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年4月15日 - (亚太商讯 via SeaPRwire.com) - 4月13-14日，2026年世界互联网大会亚太峰会在香港会议展览中心举办。百望股份首席战略官刘扬发表了题为《全球税务合规：从"财税数字化"到"中国企业商业信用基础设施"》的主题演讲，深度分享百望股份全球化战略布局与落地进程，全面展示了百望以AI Agent重构跨境税务合规体系、搭建中国企业商业信用基础设施的创新实践。 本次峰会以"数智赋能 创新发展——携手构建网络空间命运共同体"为主题，由世界互联网大会主办，香港特别行政区政府承办，香港特别行政区政府创新科技及工业局等协办。香港特别行政区行政长官李家超出席开幕式并致辞。来自全球50余个国家和地区的政府部门部长级官员、国际组织高级别代表、驻华使节、互联网领军企业代表，以及专家学者等约千名嘉宾参会。百望以商业信用模型架构为核心，筑造AI能力壁垒本次世界互联网大会的亮相，是百望股份上市以来完成AI战略转型后，首次在世界级行业论坛的重磅发声，也是企业全球化战略的一次全面公开发布。会上，百望股份宣告已完成全球化智能科技公司的全面能力准备，以商业信用模型为核心架构，正式开启全球化发展新篇章。百望股份是本次大会中唯一一家实现垂直大模型企业级应用落地、且拥有规模化真实商业案例的企业，充分印证了在AI企业级应用赛道的领先身位，全面彰显了百望股份核心战略的前瞻性与正确性，验证了以数据智能为核心、以AI Agent为抓手、以全球化布局为增长曲线的长期战略布局的精准判断。基于对AI Agent 时代企业级需求的深度理解，百望股份以动态商业信用模型为核心，完成了产品架构的全面升级，打造了"底层底座-能力中枢-智能执行"的完整闭环产品体系。百望股份之能成为中国企业商业信用基础设施的构建者，核心根基就藏在这一架构的底层设计逻辑之中。整个架构以算力平台为底层支撑，向上搭建了数据中台、AI中台、能力中台三位一体的技术中台体系。基于交易关系、商品关系、制度关系、金融关系、雇佣关系五大维度，百望股份形成了以百望企信码为底层底座，以百链、百信、百策为数据核心能力中枢，以百望百宝、百望百搭为智能执行应用的群体智能矩阵。区别于传统财税软件的功能叠加模式，百望股份打造的是可生长、可扩展的智能技术底座，这也是商业信用基础设施能够持续迭代、适配全球多元场景的核心前提。作为一家善用数据的科技公司，百望股份始终将真实交易数据作为AI时代的核心竞争力，过去十年累计处理发票超 260 亿张，沉淀了覆盖 9600万余个市场主体的海量高质量真实交易底账数据，成为企业AI 能力建设的核心燃料！百望Tax-Swift护航中企全球化征程，全面印证场景落地能力作为百望股份全球化战略的核心场景落地产品，Tax-Swift全球虚拟税务平台基于沉淀10年的监管科技与规则引擎能力，完成了全球化适配与升级，为中国企业的全球化征程搭建起全链路的合规屏障。具体而言，Tax-Swift以AI技术为核心驱动力，构建了覆盖全球税务合规全流程的闭环服务体系。平台依托全球引擎基座、发票引擎、税务规则引擎、国家适配器四层核心架构，可自动完成多语言转换、实时汇率校准、多格式报文转换、电子签名校验、智能算税算法、合规风险过滤、税收优惠适配等全流程操作，实现了企业ERP系统到全球各国税务系统的无缝直连，可深度适配全球主流税务监管体系。目前，平台已覆盖10余种主流语言、200余种票据格式标准、3万余条国际财税规则，已在多个中企出海场景落地见效。例如，某中国餐饮集团出海越南时，接入Tax-Swift平台后，顺利完成了越南当地门店的税务合规体系搭建，实现了规模化落地。今年初，百望再度升级推出Tax-Swift Bai-Claw（全球税务数字员工平台），可覆盖全球50余个国家和地区的财税合规需求，AI数字员工全面掌握权威财税政策、行业知识与专业技能，可根据企业需求定制化部署，成为中企出海随身随行的合规哨兵。百望股份CSO刘扬在演讲中表示："政策、数据、AI与全球化正在形成新的共振。交易无国界，纳税有主权，全球数字贸易正在进入主权卡位与信用卡位的全新阶段。百望股份期望以本次峰会为契机，持续深化技术创新与产业实践，以数智能力筑牢中国企业出海的合规屏障，以商业信用基础设施赋能全球贸易的高质量发展，携手各界伙伴共同赋能国家一带一路战略，为构建网络空间命运共同体贡献力量。"随着AI技术的持续深化与全球化布局的稳步推进，百望股份正在以技术创新打破跨境贸易的合规壁垒，为中国企业出海铺就一条安全、高效的数字化通路，在全球数字贸易的新赛道上，书写中国科技企业的全新篇章。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - April 14, 2026) - Doubleview Gold Corp. (TSXV: DBG) (OTCQB: DBLVF) (FSE: 1D4) ("Doubleview" or the "Company") is pleased to announce that it has filed the independent National Instrument 43-101 Technical Report entitled "Preliminary Economic Assessment of the Hat Polymetallic Project, British Columbia, Canada" (the "Technical Report") on SEDAR+ at www.sedarplus.ca and it can also be viewed on the Company's website at www.doubleview.ca. The Technical Report supports the positive Preliminary Economic Assessment ("PEA") results for the Company's 100%-owned Hat polymetallic porphyry project ("Hat" or the "Project"), located in northwestern British Columbia, as announced on March 2, 2026 and clarified on March 23, 2026.The PEA demonstrates robust project economics for the Hat Project, including:NPV:After-tax NPV(5%) of C$6.73 billion and IRR of 23% at Consensus Metal PricesAfter-tax NPV(5%) of C$13.53 billion and IRR of 39% at Spot Metal PricesNPV Including scandium and the associated processing circuit:After-tax NPV(5%) of C$7.27 billion and IRR of 19% at Consensus Metal PricesAfter-tax NPV(5%) of C$14.85 billion and IRR of 32% at Spot Metal PricesThree processing scenarios were evaluated-Scenario A1 (A1) a Cu-Au-Ag-Co flotation base case using current testwork recoveries1, Scenario A2 (A2), the same base case using expected recoveries1, and Scenario B (B), a Cu-Au-Ag-Co flowsheet with an added hydrometallurgical circuit and scandium recovery circuit, with results indicating the Project is financially attractive even without the scandium component.Highlights:Robust Project Economics: The PEA demonstrates a high-margin operation with an After-Tax NPV(5%) of C$4.96 billion (A1), C$6.73 billion (A2), or C$7.27 billion (B), and an IRR of 19% (A1), 23% (A2), or 19% (B) at analyst consensus metal prices2. Using a spot-price scenario3, the Project delivers a compelling after-tax NPV(5%) of C$11.05 billion (A1), C13.53 billion (A2), or C$14.85 billion (B) and an IRR of 34% (A1), 39% (A2), or 32% (B).Sensitivity Highlight: Project economics show the greatest leverage to overall metal prices, with NPV (5%) ranging from C$3.2 billion to C$10.2 billion (IRR: 14%-32%) at ±20% on all metals; even under additional +20% CAPEX and +20% OPEX sensitivities, applied on top of a 25% contingency already embedded in the base case, all scenarios deliver IRRs of 16% or better, and Scenario B provides additional scandium oxide upside with NPV(5%) of C$6.5 billion-C$8.1 billion (IRR: 18%-20%) at ±40% metal price.Scale and Longevity: The mine plan supports a multi-decade life of 25 years at a 120,000 tonnes-per-day processing rate, underpinned by a resource base of 609 Mt at 0.43% CuEq4 in the Measured and Indicated categories and 503 Mt at 0.41% CuEq4 in the Inferred category.High-Output Production Profile B: Envisioned as a conventional large-scale open-pit operation, the Project is expected to produce an average of over 74 kt of copper, 254 koz of gold, 376 koz of silver and 2.7 kt of cobalt annually during the first 10 years, with life-of-mine (LOM) average production of 67.6 kt Cu, 217 koz Au, 348 koz Ag, 2.5 kt Co, and 128 tonnes of scandium oxide per year. (NOTE: based on publicly reported 2024 North American cobalt mine production of approximately 3,800-4,000 tonnes (Natural Resources Canada; U.S. Geological Survey), the projected cobalt output is estimated to represent approximately 69% of current regional mined supply).Strategic Importance for Critical Minerals: The Project is positioned as a primary North American source of copper, scandium, and cobalt. With approximately 2.42 billion pounds of copper, 80 million pounds of cobalt and 2,415 tonnes of scandium oxide contained5 in the Measured and Indicated categories, the Project represents an important discovery of critical minerals.Stable, Supportive Jurisdiction: Located in a premier mining district in British Columbia, the Project benefits from a stable regulatory environment. The Company is committed to engaging with local First Nations in a respectful manner and to working toward positive and constructive relationships as the Project advances.Catalyst for Development: The PEA serves as the technical foundation for an immediate transition into a Pre-Feasibility Study (PFS), providing a clear roadmap for early works and permitting activities in 2026 and 2027.Farshad Shirvani, President and CEO of Doubleview Gold Corp., commented: "The filing of the full PEA Technical Report solidifies the robust economics outlined in March. With an after-tax NPV(5%) reaching up to C$7.27 billion at consensus prices and up to C$14.85 billion at spot prices, we believe the Hat Project is emerging as a Tier 1 asset. It is a large-scale, long-life polymetallic opportunity in a premier jurisdiction with strong exposure to critical metals including copper, scandium and cobalt. We look forward to advancing this strategic asset toward pre-feasibility while continuing to unlock value from its copper, gold, scandium and cobalt potential."The Company cautions that the PEA is preliminary in nature and includes inferred mineral resources that are considered too speculative geologically to have the economic considerations applied to them that would enable them to be categorized as mineral reserves. There is no certainty that the PEA will be realized. Mineral resources that are not mineral reserves do not have demonstrated economic viability.Qualified PersonsThe Technical Report was prepared in accordance with National Instrument 43-101 - Standards of Disclosure for Mineral Projects. The scientific and technical information contained in this news release has been reviewed and approved by the following Qualified Persons, each responsible for their respective areas of the Technical Report:Tomasz Wawruch - Geology and Mineral Resource EstimateShervin Teymouri - Mining engineering, capital and operating cost estimates, financial analysisAndrew Carter - Metallurgical testwork, recovery assumptions, and process metallurgyAndre de Ruijter - Process design, plant engineering, and process capital and operating costsFranky Li - Tailings management and tailings storage facility designJayesh Rami - Site infrastructure, civil works, access roads, and supporting facilitiesDoubleview acknowledges that the Project is located on the traditional territories of the Tahltan Nation and the Taku River Tlingit First Nation, and recognizes their enduring relationship to and stewardship of the land and waters. Doubleview is committed to respectful, transparent, and ongoing engagement with First Nations and local communities whose territories overlap the Project area and access routes, with a focus on protecting water and the environment and advancing responsible development.Readers are encouraged to review the full Technical Report on the Company's website at www.doubleview.ca and on SEDAR+ at www.sedarplus.ca for complete details, assumptions, risks, sensitivities, and qualifications.About Doubleview Gold Corp.Doubleview Gold Corp., a mineral resource exploration and development company based in Vancouver, British Columbia, Canada, is publicly traded on the TSX Venture Exchange (TSXV: DBG), the OTCQB (DBLVF), the Berlin Stock Exchange (GER: A1W038), and the Frankfurt Stock Exchange (1D4). Doubleview identifies, acquires, and finances precious and base metal exploration projects in North America, particularly in British Columbia. The Company increases shareholder value through the acquisition and exploration of quality gold, copper, cobalt, scandium, and silver properties-collectively critical minerals-and through the application of advanced, state-of-the-art exploration methods. Doubleview's portfolio of strategic properties provides diversification and mitigates investment risk.On behalf of the Board of Directors,Farshad ShirvaniPresident & CEOOn behalf of the Board of Directors,Farshad Shirvani, President & Chief Executive OfficerFor further information please contact:Doubleview Gold CorpVancouver, BC Farshad ShirvaniPresident & CEOInstitutional Line: (604) 607-5470T: (604) 678-9587E: corporate@doubleview.caNEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.Certain of the statements made and information contained herein may constitute "forward-looking information." In particular references to the Mineral Resource Estimate and future work programs or expectations on the quality or results of such work programs are subject to risks associated with operations on the property, exploration activity generally, equipment limitations and availability, as well as other risks that we may not be currently aware of. Accordingly, readers are advised not to place undue reliance on forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information, whether as a result of new information, future events or otherwise.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/292439 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

ATLANTA, GA, Apr 14, 2026 - (ACN Newswire via SeaPRwire.com) - OMP, a leader in AI-powered supply chain planning, is bringing Procter & Gamble to the Gartner Supply Chain Symposium/Xpo™ 2026 in Orlando to present its autonomous supply chain transformation. The consumer goods giant will share how it is building capabilities, enhancing data foundations, and redesigning operations around decision quality with OMP's Unison Planning™.The Gartner stage appearance caps a period of significant recognition for the collaboration. OMP was named one of six recipients of P&G's External Business Partner Excellence Award in the Global Business Services and IT category, recognizing innovation, commercial impact, and operational excellence across P&G's network of more than 50,000 global partners.P&G's journey to autonomous, decision-centric planning at scaleDaniela Cima, One Supply Transformation Senior Vice President, and Renato Scaini, Supply Chain Platform Transformation and IT Planning Vice President, will share how P&G is redefining what autonomous, decision-centric planning looks like in practice. This session will explore how P&G's "One Supply Chain Strategy" is building enhanced data foundations, redesigning operations, and embedding decision quality across its supply chain.The goal is an empowered team that spends less time on routine tasks and more time on high-value decision-making, elevating performance across the entire value chain. Attendees will walk away with concrete insights into the structures, culture, and enablers shaping P&G's next era of intelligent planning at scale, with decision velocity at the heart of it all.Sign up for the sessionAstraZeneca leads CSCO Boardroom on autonomous planningOMP is also hosting an exclusive CSCO Boardroom session on Monday, May 4 (4:00-4:45 PM), featuring Arun Krishnan, SVP of Global Supply Chain & Strategy at AstraZeneca, and Philip Vervloesem, Chief Commercial & Markets Officer at OMP. The session explores how AstraZeneca is moving away from periodic cycles toward always-on, decision-centric operations at scale, covering the operating model choices, governance structures, and talent and technology investments that shape that path. Seating is limited and available on request.Request your sessionExplore decision velocity at the OMP boothOMP will be present throughout the Gartner Supply Chain Symposium/Xpo™ (May 5 to 7, Orlando) at booth 322, demonstrating how Unison Planning™ helps organizations move beyond calendar-based planning toward always-on supply chain orchestration. See how integrated planning, enhanced by the latest AI advancements, improves scenario modeling, strengthens collaboration, and drives measurable business results.Join OMP at Gartner to hear P&G's and AstraZeneca's journeys firsthand and discover how to accelerate your path to smarter, faster supply chain decisions. Get in touch.Session at a glanceTitle: "OMP: How P&G is pioneering the next era of autonomous supply chain orchestration"Speakers:Daniela Cima - One Supply Transformation SVP at P&GRenato Scaini - Supply Chain Platform Transformation and IT Planning VP at P&GWhen: Tuesday, May 5, 2026, 11:30 AM - 12:00 PMWhere: Walt Disney World Swan and Dolphin Resort, Orlando, FLTo see where you can meet OMP next, visit their events calendar here.Solution and product inquiriesContact OMP+32 3 650 22 11Media inquiriesKira Perdue (Carabiner)SOURCE: OMP Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

PHILADELPHIA, PA, Apr 14, 2026 - (ACN Newswire via SeaPRwire.com) - Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset ("RWA") tokenization technologies, and AgSensor Solutions, LLC ("AgSensor") today announced the closing of a definitive consulting partnership agreement to identify, value, and tokenize high-value agricultural data assets.The partnership enables Datavault AI to leverage AgSensor's deep domain expertise in the agricultural technology sector to source and vet companies with significant data assets suitable for the Company's patented Information Data Exchange® ("IDE"), DataScore®, and DataValue® blockchain tokenization platforms. The consulting partnership targets key segments including soil sensing, carbon and sustainability data, agricultural IoT platforms, and regenerative agriculture environmental, social, and governance data firms.By integrating AgSensor's specialized industry knowledge with Datavault AI's monetization infrastructure, the companies aim to create a new class of liquid, transparent digital assets derived from the $5 trillion global agricultural economy1. This initiative provides agricultural producers and technology providers with a compliant pathway - consistent with applicable securities, data privacy, and anti-money-laundering regulations - to unlock the latent value of their data while offering investors exposure to critical sustainability and food security metrics.Nathaniel T. Bradley, CEO of Datavault AI, stated: "Our partnership with AgSensor Solutions is a pivotal step in expanding our RWA tokenization strategy into the vital agricultural sector. Data is the new crop for the modern farmer, and by applying our patented valuation and exchange technologies to soil and sustainability metrics, we are creating a transparent marketplace for agricultural intelligence. This consulting partnership ensures that high-value ag-data is properly qualified and positioned for global monetization."Michael J. DeSa, Co-Founder and CEO of AgSensor, added: "Partnering with Datavault AI allows us to bridge the gap between advanced agricultural sensing and the digital economy. There is an immense volume of high-quality data being generated in the field that remains undervalued. Through this agreement, we are providing the industry with the tools to tokenize these assets, driving new revenue streams for regenerative practices and enhancing the overall value of the agricultural data ecosystem."The strategic alignment focuses on sourcing prospects with high-value data assets, refining product positioning for the agricultural market, and facilitating the integration of these assets into Datavault AI's product lines. This transaction further solidifies Datavault AI's leadership in tokenizing diverse real-world assets and establishes a benchmark for the valuation and exchange of strategic agricultural data.1 According to the Food and Agriculture Organization of the United Nations (FAO), the gross value of global primary agricultural production exceeds $5 trillion annually. Source: World Bank/FAO (2024), https://blogs.worldbank.org/en/voices/do-costs-global-food-system-outweigh-its-monetary-valueAbout Datavault AI Inc.Datavault AI™ (NASDAQ:DVLT) is a pioneer in AI-driven data experiences, valuation, and monetization of assets in the Web 3.0 environment. The Company's cloud-based platform delivers comprehensive solutions across its Acoustic Sciences and Data Sciences divisions. Datavault AI's Acoustic Sciences division features WiSA®, ADIO®, and Sumerian® patented technologies for spatial and multichannel wireless, high-definition sound transmission, including intellectual property covering audio timing, synchronization, and multi-channel interference cancellation.The Data Science Division harnesses Web 3.0 and high-performance computing to enable experiential data perception, valuation, and secure monetization. The platform serves multiple industries, including sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy, and more.The IDE enables Digital Twins and licensing of name, image, and likeness by securely attaching physical real-world objects to immutable metadata, fostering responsible AI with integrity. Datavault AI's technology suite is fully customizable and includes AI and machine learning automation, third-party integration, detailed analytics, marketing automation, and advertising monitoring. The Company is headquartered in Philadelphia, PA. Learn more at www.datavaultsite.com.About AgSensor SolutionsAgSensor Solutions is a strategic consultancy specializing in the identification and optimization of agricultural technology and data assets. The firm focuses on connecting high-value agricultural data providers with advanced monetization and exchange platforms to drive innovation in soil health, carbon sequestration, and sustainable farming. Learn more at www.agsensorsolutions.com.Forward-Looking Statements: This press release contains "forward-looking statements" (within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and other securities laws) about Datavault AI Inc. ("Datavault AI," the "Company," "us," "our," or "we") and our industry that involve risks and uncertainties. Such forward-looking statements include, but are not limited to, statements regarding future events, the expected benefits of the consulting partnership with AgSensor, anticipated suitability of the Company's proprietary IDE, DataScore®, and DataValue® platforms to digitize ownership interests in the agriculture sector through blockchain-based tokenization, and expected operational, technical, and commercial outcomes of the Company's commercial strategy, and the projected direction and market impacts of regulatory changes with respect to digital assets.Actual results may differ materially from those indicated by these forward-looking statements as a result of various risks and uncertainties including, but not limited to, the following: the ability of the Company and AgSensor to identify, value and tokenize agricultural data assets; the performance, timing, or success of the deployment of the Company's proprietary IDE, DataScore®, and DataValue® platforms; changes in market demand for Datavault AI's services and products; changes in economic, market, or regulatory conditions; risks relating to evolving regulatory frameworks applicable to tokenized assets; risks associated with technological development and integration; and other risks and uncertainties as more fully described in Datavault AI's filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2025 and other filings that Datavault AI makes from time to time with the SEC, which are available on the SEC's website at www.sec.gov.The forward-looking statements made in this press release relate only to events as of the date on which the statements are made. Datavault AI undertakes no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law. Datavault AI may not actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements, and you should not place undue reliance on such forward-looking statements. Datavault AI's forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments it may make.Media Contactmarketing@dvlt.aiInvestor ContactEdward BargerVP, Investor Relationsir@dvlt.aiebarger@dvlt.aiSOURCE: Datavault AI Inc Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

佐治亚州亚特兰大, 2026年4月14日 - (亚太商讯 via SeaPRwire.com) - 人工智能驱动的供应链规划领导者OMP将携手宝洁公司（Procter & Gamble）亮相奥兰多举办的2026年Gartner供应链研讨会/博览会™，展示其自主供应链转型实践。这家消费品巨头将分享其如何借助OMP的Unison Planning™平台，围绕决策质量构建能力、强化数据基础并重塑运营。此次在Gartner大会上的亮相，标志着双方合作获得重要认可的阶段性成果。OMP被评为宝洁“全球业务服务与IT类别”外部业务合作伙伴卓越奖的六家获奖企业之一，该奖项旨在表彰宝洁全球5万多家合作伙伴网络中展现出的创新能力、商业影响力和运营卓越性。宝洁实现大规模自主、以决策为中心的规划之旅“一体化供应转型”高级副总裁丹妮拉·西玛（Daniela Cima）与“供应链平台转型及IT规划”副总裁雷纳托·斯卡尼（Renato Scaini）将分享宝洁如何在实践中重新定义自主、以决策为中心的规划。本次会议将探讨宝洁的“一体化供应链战略”如何构建增强型数据基础、重塑运营模式，并在整个供应链中融入决策质量。其目标是打造一支赋能型团队，减少常规任务的耗时，将更多精力投入高价值的决策中，从而提升整个价值链的绩效。与会者将深入了解塑造宝洁下一代大规模智能规划的架构、文化及推动因素，而决策速度正是这一体系的核心。立即报名参加 https://pr.report/kml0 阿斯利康领衔CSCO Boardroom探讨自主规划OMP还将于5月4日（星期一）下午4:00-4:45举办一场CSCO Boardroom专属会议，特邀嘉宾包括阿斯利康全球供应链与战略高级副总裁阿伦·克里希南（Arun Krishnan）以及OMP首席商务与市场官菲利普·弗洛塞姆（Philip Vervloesem）。本次会议将探讨阿斯利康如何从周期性运营模式转向大规模的“始终在线、以决策为中心”的运营模式，涵盖塑造这一转型路径的运营模式选择、治理结构以及人才与技术投资。席位有限，需提前申请。立即预约 https://pr.report/kml9 在OMP展位探索决策速度OMP将全程参与Gartner供应链研讨会/博览会™（5月5日至7日，奥兰多），在322号展位展示Unison Planning™如何帮助企业突破基于日历的传统规划，迈向全天候的供应链协调。了解如何通过最新AI技术增强的集成规划，优化情景建模、强化协作并推动可衡量的业务成果。欢迎莅临Gartner会场，聆听宝洁（P&G）和阿斯利康（AstraZeneca）的实践经验，探索如何加速实现更智能、更快速的供应链决策。立即联系我们。会议概要主题：“OMP：宝洁如何引领自主供应链协调的下一代”演讲嘉宾：• Daniela Cima - 宝洁“一体化供应转型”高级副总裁• Renato Scaini - 宝洁公司供应链平台转型与IT规划副总裁时间：2026年5月5日（星期二）上午11:30 - 12:00地点：佛罗里达州奥兰多市华特迪士尼世界天鹅与海豚度假酒店如需了解OMP的下一场活动地点，请点击此处查看活动日历。解决方案与产品咨询联系 OMP+32 3 650 22 11媒体咨询基拉·珀杜（Carabiner）来源：OMP Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

宾夕法尼亚州费城, 2026年4月14日 - (亚太商讯 via SeaPRwire.com) - Datavault AI Inc.（“Datavault AI”或“公司”） （纳斯达克代码：DVLT），一家专注于数据变现、资质认证、数字互动及现实世界资产（“RWA”）通证化技术的供应商，与 AgSensor Solutions, LLC（“AgSensor”）今日宣布，双方已正式签署最终咨询合作协议，旨在识别、评估并实现高价值农业数据资产的通证化。此次合作使Datavault AI能够借助AgSensor在农业技术领域的深厚专业知识，发掘并筛选拥有大量数据资产且适合公司专利技术——Information Data Exchange®（“IDE”）、DataScore®及DataValue®区块链代币化平台的企业。该咨询合作瞄准了包括土壤传感、碳与可持续性数据、农业物联网平台，以及再生农业环境、社会和治理数据公司等关键领域。通过整合 AgSensor 的专业行业知识与 Datavault AI 的货币化基础设施，双方旨在从价值 5 万亿美元的全球农业经济1 中，创造出一类全新的、具有流动性和透明度的数字资产。该举措为农业生产者和技术提供商提供了一条合规路径——符合适用的证券、数据隐私和反洗钱法规——以释放其数据的潜在价值，同时为投资者提供接触关键可持续性和粮食安全指标的机会。Datavault AI首席执行官纳撒尼尔·T·布拉德利（Nathaniel T. Bradley）表示：“与AgSensor Solutions的合作是将我们的RWA代币化战略扩展至关键农业领域的关键一步。数据是现代农户的新作物，通过将我们专利的估值和交易技术应用于土壤及可持续性指标，我们正在构建一个透明的农业智能市场。此次咨询合作将确保高价值农业数据经过严格认证，并为全球变现做好充分准备。”AgSensor联合创始人兼首席执行官迈克尔·J·德萨（Michael J. DeSa）补充道：“与Datavault AI的合作使我们能够弥合先进农业传感技术与数字经济之间的鸿沟。田间正产生海量高质量数据，但其价值尚未得到充分体现。通过此次合作，我们将为行业提供将这些资产通证化的工具，为再生农业实践开辟新的收入来源，并提升农业数据生态系统的整体价值。”此次战略合作将重点关注发掘拥有高价值数据资产的潜在客户，优化农业市场的产品定位，并推动这些资产与Datavault AI产品线的整合。此次交易进一步巩固了Datavault AI在多元化现实世界资产代币化领域的领导地位，并为战略性农业数据的估值与交易树立了标杆。1 根据联合国粮食及农业组织（FAO）的数据，全球初级农业生产总值每年超过5万亿美元。来源：世界银行/FAO（2024）， https://blogs.worldbank.org/en/voices/do-costs-global-food-system-outweigh-its-monetary-value 关于 Datavault AI Inc.Datavault AI™（纳斯达克代码：DVLT）是 Web 3.0 环境中人工智能驱动的数据体验、资产估值及货币化领域的先驱。公司基于云的平台通过其声学科学和数据科学两大部门提供全面解决方案。Datavault AI的声学科学部门拥有WiSA®、ADIO®和Sumerian®等专利技术，用于空间和多声道无线高清音频传输，其知识产权涵盖音频时序、同步及多声道干扰消除等领域。关于 AgSensor SolutionsAgSensor Solutions 是一家专注于识别和优化农业技术及数据资产的战略咨询公司。该公司致力于将高价值农业数据提供商与先进的变现和交易平台对接，以推动土壤健康、碳封存和可持续农业领域的创新。了解更多信息，请访问 www.agsensorsolutions.com 。前瞻性陈述：本新闻稿包含关于 Datavault AI Inc.（“Datavault AI”、“本公司”、“我们”或“我们的”）及其所处行业的“前瞻性陈述”（定义见经修订的《1995 年私人证券诉讼改革法案》及其他证券法律），其中涉及风险和不确定性。此类前瞻性陈述包括但不限于：关于未来事件的陈述；与 AgSensor 建立咨询合作伙伴关系的预期效益；本公司专有的 IDE、DataScore® 和 DataValue® 平台通过基于区块链的代币化实现农业领域所有权权益数字化的预期适用性；本公司商业战略的预期运营、技术和商业成果；以及数字资产相关监管变化的预期方向和市场影响。由于各种风险和不确定性，包括但不限于以下方面，实际结果可能与这些前瞻性陈述所指明的结果存在重大差异：本公司与AgSensor识别、评估和代币化农业数据资产的能力； 本公司专有IDE、DataScore®及DataValue®平台的部署表现、时间安排或成功与否；市场对Datavault AI服务及产品的需求变化；经济、市场或监管环境的变化；与代币化资产相关且不断演变的监管框架相关的风险； 与技术开发和集成相关的风险；以及 Datavault AI 向美国证券交易委员会（SEC）提交的文件中更详细描述的其他风险和不确定性，包括截至 2025 年 12 月 31 日的 10-K 年度报告以及 Datavault AI 不时向 SEC 提交的其他文件，这些文件可在 SEC 网站 www.sec.gov 上查阅。本新闻稿中作出的前瞻性陈述仅涉及陈述作出之日的事件。Datavault AI 无义务更新本新闻稿中的任何前瞻性陈述，以反映本新闻稿发布日之后的事件或情况，或反映新信息或意外事件的发生，除非法律另有要求。Datavault AI 可能无法实际实现其前瞻性陈述中披露的计划、意图或预期，您不应过度依赖此类前瞻性陈述。Datavault AI 的前瞻性陈述未反映其未来可能进行的任何收购、合并、资产处置、合资或投资所带来的潜在影响。媒体联系marketing@dvlt.ai 投资者联系Edward Barger投资者关系副总裁ir@dvlt.ai ebarger@dvlt.ai 来源：Datavault AI Inc Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

TAMPA, FLA., Apr 14, 2026 - (ACN Newswire via SeaPRwire.com) - Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a leading healthcare technology and pharmaceutical distribution company, today announced the execution of a definitive joint venture agreement with Kare PharmTech's wholly owned subsidiary, Kare Rx Hub, LLC ("KareRx"), an artificial intelligence (AI)-driven digital hub supporting retail pharmacy, telemedicine, and specialty pharmaceutical programs.The execution of the joint venture formalizes the previously announced non-binding letter of intent and represents a significant milestone in aligning both organizations' technology platforms and operational teams into a unified ecosystem designed to accelerate patient access and improve the efficiency of pharmaceutical commercialization. By integrating the Wellgistics Hub technology stack including proprietary platforms EinsteinRx™ and HubRx AI™ with KareRx's digital hub, the combined platform is positioned to streamline the prescription journey from intake through fulfillment.Prashant Patel, Chief Executive Officer of Wellgistics Health, commented, "This joint venture reflects our continued focus on building an integrated, technology-enabled platform to improve coordination across the prescription journey and support patient access to therapies. By combining KareRx's provider connectivity and digital engagement capabilities with our infrastructure, we believe this collaboration enhances operational efficiency and supports manufacturers and other healthcare stakeholders in navigating access pathways more effectively."The joint venture aligns clinical, operational, and commercial teams across both organizations, enabling more seamless coordination between providers, pharmacies, and patients. Through this integration, the platform enhances key capabilities including eligibility and benefits verification, prior authorization workflows, prescription routing, and direct-to-patient fulfillment. The combined ecosystem includes a growing national footprint of independent pharmacies, provider networks, and telehealth channels, with the ability to reach more than 200,000 patient lives based on third-party internal estimates.Mital Panera, Founder and Chief Executive Officer of KareRx, added, "KareRx was developed to connect providers, pharmacies, and patients through technology-driven solutions. This joint venture allows us to extend those capabilities by leveraging Wellgistics' technology stack, pharma expertise, and operational infrastructure. We believe the combined platform will support improved connectivity across stakeholders and facilitate access to therapies across participating networks."The collaboration further strengthens direct-to-patient (DTP) and decentralized care models, providing pharmaceutical manufacturers with a comprehensive platform that integrates access, affordability, and fulfillment into a single solution. Leveraging AI-driven insights and a fully integrated operational backbone, the joint venture is designed to reduce barriers to therapy initiation, improve adherence, and deliver enhanced visibility into patient access and program performance.The joint venture remains subject to customary implementation steps, and there can be no assurance regarding the timing or extent of operational integration or the realization of anticipated benefits. Additional details regarding the joint venture agreement will be provided in a Current Report on Form 8-K to be filed by the Company with the U.S. Securities and Exchange Commission.About Wellgistics Health, Inc.Wellgistics Health (NASDAQ:WGRX) is a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™ to optimize the prescription drug dispensing journey. Its integrated platform connects 6,500+ pharmacies (the "Wellgistics Pharmacy Network") and 200+ manufacturers, offering wholesale distribution, digital prescription routing, direct-to-patient delivery, and AI-powered hub services such as eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment as needed to optimize patient access. Wellgistics provides end-to-end solutions designed to restore access, transparency, and trust in the U.S. prescription drug market for independent pharmacies.About Kare PharmTech, LLCKare Rx Hub is an artificial intelligence (AI)-based digital hub for retail pharmacies, telemedicine portal, and specialty pharmaceutical ‘lite' branded products with over 500 physician-provider relationships, 200 independent pharmacy relationships that market unique specialty pharmaceutical ‘lite' products. Kare Rx Hub is owned by Kare Pharmtech, LLC, a company controlled by Dr. Kiran Patel. Dr. Patel founded Medicaid provider WellCare in 1992 and sold it in 2002 for $200 million. In 2007, Dr. Patel founded America's 1st Choice Holdings and acquired Freedom Health and Optimum Holdings. In 2017, he sold America's 1st Choice Holdings to Anthem, Inc. Dr. Patel is a noted philanthropist and was named Floridian of the Year by Florida Trend Magazine.Forward-Looking StatementsThis press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When Wellgistics Health uses words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate," or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, statements regarding Wellgistics Health's strategy and descriptions of its future operations, prospects, and plans. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause actual results to differ materially. Additional factors are discussed in Wellgistics Health's filings with the SEC, available at www.sec.gov.Wellgistics Media & Investor ContactMedia: media@wellgisticshealth.comInvestor Relations: IR@wellgisticshealth.comSOURCE: Wellgistics Health, Inc. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

佛罗里达州坦帕市, 2026年4月14日 - (亚太商讯 via SeaPRwire.com) - Wellgistics Health, Inc. (NASDAQ:WGRX) （“Wellgistics”或“公司”），一家领先的医疗健康技术与药品分销公司，今日宣布已与Kare PharmTech的全资子公司Kare Rx Hub, LLC（“KareRx”）签署最终合资协议。KareRx是一家由人工智能（AI）驱动的数字枢纽，致力于支持零售药房、远程医疗及专科药品项目。此次合资协议的签署正式确立了此前公布的非约束性意向书，标志着双方将技术平台和运营团队整合为统一生态系统的重大里程碑，旨在加速患者用药可及性并提升药品商业化的效率。通过将Wellgistics Hub技术栈（包括专有平台EinsteinRx™和HubRx AI™）与KareRx的数字枢纽进行整合，该联合平台将能够优化从处方接收至履约的全流程。Wellgistics Health首席执行官Prashant Patel表示：“此次合资体现了我们持续致力于构建一个集成化、技术驱动的平台，以改善处方全流程的协调性，并支持患者获得治疗。通过将KareRx的医疗服务提供商连接能力与数字化互动能力与我们的基础设施相结合，我们相信此次合作将提升运营效率，并帮助制药商及其他医疗保健利益相关方更有效地规划药物准入路径。”该合资企业整合了两家公司的临床、运营和商业团队，实现了医疗服务提供者、药房和患者之间的无缝协作。通过此次整合，该平台增强了关键功能，包括资格和福利核验、事前授权工作流、处方路由以及直接面向患者的配药服务。整合后的生态系统覆盖范围日益扩大，涵盖全国范围内的独立药房、医疗服务提供商网络及远程医疗渠道，据第三方内部估算，其服务覆盖患者人数已超过20万。KareRx创始人兼首席执行官米塔尔·帕内拉（Mital Panera）补充道：“KareRx的创立初衷是通过技术驱动的解决方案连接医疗服务提供者、药房和患者。此次合资企业使我们能够借助Wellgistics的技术栈、制药专业知识和运营基础设施，进一步扩展这些能力。我们相信，整合后的平台将支持各利益相关方之间更紧密的连接，并促进参与网络内疗法的获取。”此次合作进一步强化了直达患者（DTP）和去中心化护理模式，为制药企业提供了一个将治疗可及性、可负担性和履约能力整合于一体的综合平台。依托人工智能驱动的洞察力和完全集成的运营体系，该合资企业旨在降低治疗启动门槛、提高治疗依从性，并增强对患者治疗可及性和项目绩效的可视化管理。该合资企业仍需遵循惯例的实施步骤，其运营整合的时间表、范围以及预期效益能否实现均无法保证。关于合资协议的更多详情，将在公司向美国证券交易委员会提交的8-K表格《当前报告》中披露。关于 Wellgistics Health, Inc.Wellgistics Health（纳斯达克股票代码：WGRX）是一家健康信息技术领域的领导者，将专有的药房配药优化人工智能平台 EinsteinRx™ 整合到其获得专利的基于区块链的智能合约平台 PharmacyChain™ 中，以优化处方药配药流程。其集成平台连接了 6,500 多家药房（“Wellgistics 药房网络”）和 200 多家制造商，提供批发分销、数字处方路由、直接送达患者以及由人工智能驱动的枢纽服务，例如资格审核、用药依从性管理、新用户入网、预授权以及按需现金支付履约服务，以优化患者的用药获取渠道。Wellgistics 提供端到端解决方案，旨在为美国独立药房恢复处方药市场的可及性、透明度和信任。关于 Kare PharmTech, LLCKare Rx Hub 是一个基于人工智能（AI）的数字枢纽，服务于零售药房、远程医疗门户以及特色药品“轻量版”品牌产品，拥有超过 500 家医生服务提供商合作关系，以及 200 家推广独特特色药品“轻量版”产品的独立药房合作关系。Kare Rx Hub 由 Kare Pharmtech, LLC 所有，该公司由 Kiran Patel 博士控制。Patel 博士于 1992 年创立了 Medicaid 服务提供商 WellCare，并于 2002 年以 2 亿美元的价格将其出售。2007 年，Patel 博士创立了 America's 1st Choice Holdings，并收购了 Freedom Health 和 Optimum Holdings。2017年，他将America's 1st Choice Holdings出售给Anthem, Inc.。帕特尔博士是一位知名慈善家，曾被《佛罗里达趋势》杂志评为“年度佛罗里达人”。前瞻性陈述本新闻稿可能包含前瞻性陈述。前瞻性陈述包括有关计划、目标、战略、未来事件或业绩的陈述，以及基本假设和其他非历史事实的陈述。当Wellgistics Health使用“可能”、“将”、“打算”、“应该”、“相信”、“预期”、“预计”、“预测”、“估计”或类似表述，且这些表述并非仅涉及历史事实时，即构成前瞻性陈述。这些前瞻性陈述包括但不限于关于Wellgistics Health战略的陈述，以及对其未来运营、前景和计划的描述。前瞻性陈述并非对未来业绩的保证，且涉及可能导致实际结果出现重大差异的风险和不确定性。其他相关因素详见Wellgistics Health向美国证券交易委员会（SEC）提交的文件，该文件可于www.sec.gov查阅。Wellgistics 媒体与投资者联系方式媒体：media@wellgisticshealth.com投资者关系：IR@wellgisticshealth.com来源：Wellgistics Health, Inc. Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com